JP4570905B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP4570905B2 JP4570905B2 JP2004146642A JP2004146642A JP4570905B2 JP 4570905 B2 JP4570905 B2 JP 4570905B2 JP 2004146642 A JP2004146642 A JP 2004146642A JP 2004146642 A JP2004146642 A JP 2004146642A JP 4570905 B2 JP4570905 B2 JP 4570905B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- manufactured
- acid
- skin
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 31
- 230000000699 topical effect Effects 0.000 title 1
- -1 polysaccharide compound Chemical class 0.000 claims description 157
- 239000000843 powder Substances 0.000 claims description 79
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 68
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 68
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 68
- 239000002131 composite material Substances 0.000 claims description 52
- 229940008099 dimethicone Drugs 0.000 claims description 42
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 41
- 229920001282 polysaccharide Polymers 0.000 claims description 38
- 239000005017 polysaccharide Substances 0.000 claims description 38
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 28
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 26
- 229920006037 cross link polymer Polymers 0.000 claims description 23
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 18
- 229920002554 vinyl polymer Polymers 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 14
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 125000000962 organic group Chemical group 0.000 claims description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 5
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 claims description 4
- 125000001033 ether group Chemical group 0.000 claims description 4
- 125000005647 linker group Chemical group 0.000 claims description 4
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 64
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 35
- 229920001296 polysiloxane Polymers 0.000 description 35
- 239000000284 extract Substances 0.000 description 33
- 239000004373 Pullulan Substances 0.000 description 31
- 229920001218 Pullulan Polymers 0.000 description 31
- 235000019423 pullulan Nutrition 0.000 description 31
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 29
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 28
- 239000010410 layer Substances 0.000 description 27
- 239000007983 Tris buffer Substances 0.000 description 26
- 239000003054 catalyst Substances 0.000 description 26
- 230000000694 effects Effects 0.000 description 26
- UAXUIYBGZNXVCN-UHFFFAOYSA-N 3-silylpropylcarbamic acid Chemical compound [SiH3]CCCNC(O)=O UAXUIYBGZNXVCN-UHFFFAOYSA-N 0.000 description 25
- 239000002253 acid Substances 0.000 description 25
- 229940041514 candida albicans extract Drugs 0.000 description 25
- 229920001577 copolymer Polymers 0.000 description 25
- 229920002379 silicone rubber Polymers 0.000 description 25
- 239000012138 yeast extract Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 21
- 150000002148 esters Chemical class 0.000 description 21
- 229910052809 inorganic oxide Inorganic materials 0.000 description 21
- 239000000454 talc Substances 0.000 description 21
- 229910052623 talc Inorganic materials 0.000 description 21
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 20
- 238000009472 formulation Methods 0.000 description 20
- 239000000377 silicon dioxide Substances 0.000 description 19
- 239000010445 mica Substances 0.000 description 18
- 229910052618 mica group Inorganic materials 0.000 description 18
- 239000008213 purified water Substances 0.000 description 17
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 16
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 16
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 14
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000010936 titanium Substances 0.000 description 14
- 229910052719 titanium Inorganic materials 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 12
- 229940042585 tocopherol acetate Drugs 0.000 description 12
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 11
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 11
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- 229960005323 phenoxyethanol Drugs 0.000 description 11
- 229940047670 sodium acrylate Drugs 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 description 10
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 10
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 10
- 239000004375 Dextrin Substances 0.000 description 9
- 229920001353 Dextrin Polymers 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 235000019425 dextrin Nutrition 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 9
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 9
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 8
- 239000002304 perfume Substances 0.000 description 8
- 229940032094 squalane Drugs 0.000 description 8
- 239000011787 zinc oxide Substances 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 7
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 6
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 6
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 150000004804 polysaccharides Chemical class 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- 229920002050 silicone resin Polymers 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 5
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 5
- 240000000912 Macadamia tetraphylla Species 0.000 description 5
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000011247 coating layer Substances 0.000 description 5
- 229960000735 docosanol Drugs 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 5
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 239000010466 nut oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 4
- NDHNBHXAALUAAJ-UHFFFAOYSA-N 4,5-dimorpholin-4-yl-1h-pyridazin-6-one Chemical compound C1COCCN1C=1C(O)=NN=CC=1N1CCOCC1 NDHNBHXAALUAAJ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 4
- 229910000271 hectorite Inorganic materials 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 229910052628 phlogopite Inorganic materials 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229940048053 acrylate Drugs 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000010389 delta-tocopherol Nutrition 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 238000010030 laminating Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 235000020712 soy bean extract Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002446 δ-tocopherol Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- PDQICKRFOKDJCH-INIZCTEOSA-N (2s)-6-amino-2-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCCCN PDQICKRFOKDJCH-INIZCTEOSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 244000061508 Eriobotrya japonica Species 0.000 description 2
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- 241000546188 Hypericum Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 2
- 244000288377 Saxifraga stolonifera Species 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000010410 calcium alginate Nutrition 0.000 description 2
- 239000000648 calcium alginate Substances 0.000 description 2
- 229960002681 calcium alginate Drugs 0.000 description 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229940072117 fennel extract Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 2
- 229940074358 magnesium ascorbate Drugs 0.000 description 2
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 150000002902 organometallic compounds Chemical class 0.000 description 2
- 125000006353 oxyethylene group Chemical group 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 2
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- IMMBLRJLSYJQIZ-UNQGIHKMSA-N (2S)-7-[3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one Chemical compound COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(OC3OC(COC4OC(C)C(O)C(O)C4O)C(OC4OC(CO)C(O)C(O)C4O)C(O)C3O)cc2O1 IMMBLRJLSYJQIZ-UNQGIHKMSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- BUDRQJIYQOCVNK-UHFFFAOYSA-N (3-methyl-1-silylbutyl) 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoate Chemical compound CC(C)CC([SiH3])OC(=O)C(OC)=C(OC)C1=CC=CC=C1OC BUDRQJIYQOCVNK-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241000123826 Lutjanus campechanus Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002197 Sodium polyaspartate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229960003001 adenosine triphosphate disodium Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001349 alkyl fluorides Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940082337 dimethicone 20 Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- HRUVKSKSDDVGMC-JDYVBSGKSA-L disodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Na+].[Na+].OS([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] HRUVKSKSDDVGMC-JDYVBSGKSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 230000006203 ethylation Effects 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- UCSUOYMTZRJAIH-UHFFFAOYSA-N iron(2+) oxygen(2-) titanium(4+) Chemical compound [O-2].[O-2].[Ti+4].[Fe+2] UCSUOYMTZRJAIH-UHFFFAOYSA-N 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- ORUIBWPALBXDOA-UHFFFAOYSA-L magnesium fluoride Chemical compound [F-].[F-].[Mg+2] ORUIBWPALBXDOA-UHFFFAOYSA-L 0.000 description 1
- 229910001635 magnesium fluoride Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- SIWVEOZUMHYXCS-UHFFFAOYSA-N oxo(oxoyttriooxy)yttrium Chemical compound O=[Y]O[Y]=O SIWVEOZUMHYXCS-UHFFFAOYSA-N 0.000 description 1
- WKMKTIVRRLOHAJ-UHFFFAOYSA-N oxygen(2-);thallium(1+) Chemical compound [O-2].[Tl+].[Tl+] WKMKTIVRRLOHAJ-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KBJXDTIYSSQJAI-UHFFFAOYSA-N propylcarbamic acid Chemical compound CCCNC(O)=O KBJXDTIYSSQJAI-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229910003438 thallium oxide Inorganic materials 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- LLZRNZOLAXHGLL-UHFFFAOYSA-J titanic acid Chemical compound O[Ti](O)(O)O LLZRNZOLAXHGLL-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229910000349 titanium oxysulfate Inorganic materials 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
本発明は皮膚外用剤、特に皮膜剤を含む皮膚外用剤に関する。 The present invention relates to an external preparation for skin, particularly to an external preparation for skin containing a film agent.
皮膚にハリ感を与える化粧料には、通常皮膜剤として、水溶性あるいは油溶性の高分子が配合されている。しかしながら、上記化粧料は、溶媒が揮発し皮膚上で高分子が被膜する際に生じる粘性により、べたつきが強く感じられ、使用感が良くないという欠点があった。
そこで、特開2000−34218号公報には、皮膜剤に納豆エキスを組み合わせて配合した皮膚外用剤が開示されており、該皮膚外用剤は、塗布後のべたつきが少なく、且つハリ感が感じられることが報告されている。
Cosmetics that give a firm feeling to the skin usually contain a water-soluble or oil-soluble polymer as a film agent. However, the cosmetics have the disadvantage that the stickiness is felt strongly due to the viscosity generated when the solvent is volatilized and the polymer is coated on the skin, and the feeling of use is not good.
Therefore, JP 2000-34218 A discloses a skin external preparation in which a natto extract is combined with a film agent, and the skin external preparation has little stickiness after application and feels firm. It has been reported.
近年では、メーキャップ化粧料に限らずスキンケア化粧料においても、シミ・ソバカス・くすみ等の肌の色ムラや、毛穴・小シワ等の肌の凹凸をぼかし、透明感のある肌を演出する効果が求められてきており、使用感が良いことに加え、美肌演出効果を有する皮膚外用剤が求められていた。
しかしながら、使用感と肌の補正効果の点で共に満足できるものは開発されておらず、新たな皮膚外用剤の開発が望まれていた。
本発明は前記従来技術の課題に鑑みなされたものであり、その目的は、べたつきを生じず良好なハリ感を有し、しかも美肌演出効果に優れた皮膚外用剤を提供することにある。
However, no product that satisfies both the feeling of use and the skin correction effect has been developed, and the development of a new skin external preparation has been desired.
The present invention has been made in view of the above-described problems of the prior art, and an object thereof is to provide an external preparation for skin having a good firmness without causing stickiness and having an excellent effect of producing beautiful skin.
前記目的を達成するために本発明者等が検討を行った結果、特定構造を有するシリコーン化多糖化合物と特定の無機複合粉体とを組み合わせて配合することにより、べたつきを生じず肌にハリ感を付与でき、なおかつ美肌演出効果に優れた皮膚外用剤が得られることを見出し、本発明を完成するに至った。
すなわち本発明の皮膚外用剤は、(a)下記一般式(I)で表される構造を有する0.01〜3.0質量%のシリコーン化多糖化合物と、
(b)鱗片状基材上に、屈折率が互いに異なる2種以上の無機酸化物が屈折率の高いものから順次積層してなる0.1〜20質量%の無機複合粉体とを含み、
該無機複合粉体において、最外層の無機酸化物層と、最外層と隣接する層の無機酸化物層との屈折率の差が0.6以下であることを特徴とする。
(化1)
(式(I)中、Gluは多糖化合物の糖残基であり、Xはカルボニル基、アミノ基、エーテル基、カルバモイル基、及び−CH2CH(OH)−から選ばれる2価の結合基である。Yは主鎖中に酸素原子、窒素原子、硫黄原子、フェニレン基、カルボニルオキシ基又はオキシカルボニル基を有することができ、ヒドロキシ基、アルコキシ基及びアルキル基から選ばれる置換基を有することができる総炭素数2〜8のアルキレン基である。R1は炭素数1〜8の1価有機基であり、R2、R3、R4はそれぞれ同一でも異なっても良く、炭素数1〜8の1価有機基又は−OSiR5R6R7で示されるシロキシ基である。ただし、R5、R6、R7はそれぞれ同一でも異なっても良く炭素数1〜8の1価有機基である。aは0、1又は2である。)
As a result of studies conducted by the present inventors in order to achieve the above-mentioned object, the combination of a siliconized polysaccharide compound having a specific structure and a specific inorganic composite powder allows the skin to feel firm without causing stickiness. It was found that a skin external preparation excellent in effect for producing beautiful skin can be obtained, and the present invention has been completed.
That is, the skin external preparation of the present invention comprises (a) 0.01 to 3.0% by mass of a silicone- modified polysaccharide compound having a structure represented by the following general formula (I):
(B) containing 0.1 to 20% by mass of an inorganic composite powder obtained by sequentially laminating two or more inorganic oxides having different refractive indexes from those having a high refractive index on a scaly substrate,
The inorganic composite powder is characterized in that the difference in refractive index between the outermost inorganic oxide layer and the inorganic oxide layer adjacent to the outermost layer is 0.6 or less.
(Chemical formula 1)
(In Formula (I), Glu is a sugar residue of the polysaccharide compound, X is a divalent linking group selected from a carbonyl group, an amino group, an ether group, a carbamoyl group, and —CH 2 CH (OH) —). Y may have an oxygen atom, a nitrogen atom, a sulfur atom, a phenylene group, a carbonyloxy group or an oxycarbonyl group in the main chain, and may have a substituent selected from a hydroxy group, an alkoxy group and an alkyl group. An alkylene group having 2 to 8 carbon atoms in total, R 1 is a monovalent organic group having 1 to 8 carbon atoms, and R 2 , R 3 , and R 4 may be the same or different; 8 or a siloxy group represented by —OSiR 5 R 6 R 7 , wherein R 5 , R 6 and R 7 may be the same or different and each is a monovalent organic group having 1 to 8 carbon atoms. A is 0, 1 or In is.)
前記皮膚外用剤において、式(I)中、Xがカルボニル基であることが好適である。
前記(b)無機複合粉体は、鱗片状基材上に、酸化チタン、酸化アルミニウム、酸化ケイ素の順に積層してなる無機複合粉体であることが好適である。
前記皮膚外用剤において、(a)シリコーン化多糖化合物の配合量が0.01〜3.0質量%であり、(b)無機複合粉体の配合量が0.1〜20質量%であることが好適である。
前記皮膚外用剤において、さらに、(c)ジメチコン/ビニルジメチコンクロスポリマー、ジメチコンクロスポリマー、及びビニルジメチコン/ラウリルジメチコンクロスポリマーからなる群より選択される1種又は2種以上の架橋型ポリメチルシロキサンを含むことが好適である。
In the above-mentioned external preparation for skin, in formula (I), X is preferably a carbonyl group.
The (b) inorganic composite powder is preferably an inorganic composite powder obtained by laminating titanium oxide, aluminum oxide, and silicon oxide in this order on a scaly substrate.
In the above-mentioned external preparation for skin, (a) the compounding amount of the silicone-modified polysaccharide compound is 0.01 to 3.0% by mass, and (b) the compounding amount of the inorganic composite powder is 0.1 to 20% by mass. Is preferred.
In the external preparation for skin, (c) one or two or more kinds of cross-linked polymethylsiloxane selected from the group consisting of dimethicone / vinyl dimethicone cross polymer, dimethicone cross polymer, and vinyl dimethicone / lauryl dimethicone cross polymer It is preferable to include.
本発明によれば、特定構造を有するシリコーン化多糖化合物と特定の無機複合粉体とを組み合わせて配合することにより、べたつきを生じず肌にハリ感を付与でき、なおかつ肌の補正効果に優れた皮膚外用剤を得ることができる。 According to the present invention, by blending a combination of a siliconized polysaccharide compound having a specific structure and a specific inorganic composite powder, it is possible to impart firmness to the skin without causing stickiness, and excellent skin correction effect. A skin external preparation can be obtained.
(a)シリコーン化多糖化合物
本発明において用いられるシリコーン化多糖化合物は、下記一般式(I)で示される。
(化2)
(式(I)中、Gluは多糖化合物の糖残基であり、Xはカルボニル基、アミノ基、エーテル基、カルバモイル基、及び−CH2CH(OH)−から選ばれる2価の結合基である。Yは主鎖中に酸素原子、窒素原子、硫黄原子、フェニレン基、カルボニルオキシ基又はオキシカルボニル基を有することができ、ヒドロキシ基、アルコキシ基及びアルキル基から選ばれる置換基を有することができる総炭素数2〜8のアルキレン基である。R1は炭素数1〜8の1価有機基であり、R2、R3、R4はそれぞれ同一でも異なっても良く、炭素数1〜8の1価有機基又は−OSiR5R6R7で示されるシロキシ基である。ただし、R5、R6、R7はそれぞれ同一でも異なっても良く炭素数1〜8の1価有機基である。aは0、1又は2である。)
(A) Siliconized polysaccharide compound The siliconized polysaccharide compound used in the present invention is represented by the following general formula (I).
(Chemical formula 2)
(In Formula (I), Glu is a sugar residue of the polysaccharide compound, X is a divalent linking group selected from a carbonyl group, an amino group, an ether group, a carbamoyl group, and —CH 2 CH (OH) —). Y may have an oxygen atom, a nitrogen atom, a sulfur atom, a phenylene group, a carbonyloxy group or an oxycarbonyl group in the main chain, and may have a substituent selected from a hydroxy group, an alkoxy group and an alkyl group. An alkylene group having 2 to 8 carbon atoms in total, R 1 is a monovalent organic group having 1 to 8 carbon atoms, and R 2 , R 3 , and R 4 may be the same or different; 8 or a siloxy group represented by —OSiR 5 R 6 R 7 , wherein R 5 , R 6 and R 7 may be the same or different and each is a monovalent organic group having 1 to 8 carbon atoms. A is 0, 1 or In is.)
一般式(I)において、Gluは多糖化合物の糖残基を表すが、このような多糖化合物としては、公知の各種多糖化合物を用いることができ、例えばセルロース、ヘミセルロース、アラビアガム、トラガントガム、タマリンドガム、ペクチン、デンプン、マンナン、グアーガム、ローカストビーンガム、クインスシードガム、アルギン酸、カラギーナン、寒天、キサンタンガム、デキストラン、プルラン、キチン、キトサン、ヒアルロン酸、コンドロイチン硫酸の他、これら多糖化合物の誘導体、例えば、カルボキシメチル化、硫酸化、リン酸化、メチル化、エチル化、エチレンオキサイドやプロピレンオキサイド等のアルキレンオキサイドの付加、アシル化、カチオン化、低分子量化等を行った多糖化合物誘導体が挙げられる。
これらの内、好ましくはエチルセルロース又はプルランであり、特に好ましくはプルランである。なお、本発明において多糖化合物の平均分子量は多糖化合物の種類により異なるが、通常約1,000〜5,000,000が好ましい。
In the general formula (I), Glu represents a sugar residue of a polysaccharide compound. As such a polysaccharide compound, various known polysaccharide compounds can be used, for example, cellulose, hemicellulose, gum arabic, tragacanth gum, tamarind gum. , Pectin, starch, mannan, guar gum, locust bean gum, quince seed gum, alginic acid, carrageenan, agar, xanthan gum, dextran, pullulan, chitin, chitosan, hyaluronic acid, chondroitin sulfate, and derivatives of these polysaccharide compounds such as carboxy Examples thereof include polysaccharide compound derivatives that have been subjected to methylation, sulfation, phosphorylation, methylation, ethylation, addition of alkylene oxides such as ethylene oxide and propylene oxide, acylation, cationization, and low molecular weight.
Of these, ethyl cellulose or pullulan is preferable, and pullulan is particularly preferable. In the present invention, the average molecular weight of the polysaccharide compound varies depending on the kind of the polysaccharide compound, but is usually preferably about 1,000 to 5,000,000.
Xで示される2価の結合基を例示すると、カルボニル基、アミノ基、エーテル基、カルバモイル基、及び−CH2CH(OH)、等が挙げられるが、特にカルバモイル基(=CONH−)であることが好ましい。
Yで示されるアルキレン基としては、主鎖中に酸素原子、窒素原子、硫黄原子等を有するアルキレン基、主鎖中にフェニレン基等のアリーレン基を有するアルキレン基、主鎖中にカルボニルオキシ基又はオキシカルボニル基を有するアルキレン基を挙げることができる。これらのアルキレン基はヒドロキシ基、アルコキシ基、アルキル基等の置換基を有することができ、また、アルキレン基の末端原子が酸素原子、窒素原子、硫黄原子等のヘテロ原子であってもよい。Yを例示すると、−(CH2)2−、−(CH2)3−、−(CH2)4−、−(CH2)6−、−(CH2)8−、−[CH2CH(CH3)]−、−(CH2)2O(CH2)3−、−CH2CH(OH)−CH2−等が挙げられるが、好ましくは−(CH2)3−で示されるプロピレン基である。
Examples of the divalent linking group represented by X include a carbonyl group, an amino group, an ether group, a carbamoyl group, —CH 2 CH (OH), and the like, and particularly a carbamoyl group (═CONH—). It is preferable.
As the alkylene group represented by Y, an alkylene group having an oxygen atom, a nitrogen atom, a sulfur atom or the like in the main chain, an alkylene group having an arylene group such as a phenylene group in the main chain, a carbonyloxy group in the main chain or An alkylene group having an oxycarbonyl group can be exemplified. These alkylene groups can have a substituent such as a hydroxy group, an alkoxy group, or an alkyl group, and the terminal atom of the alkylene group may be a hetero atom such as an oxygen atom, a nitrogen atom, or a sulfur atom. When Y is illustrated, — (CH 2 ) 2 —, — (CH 2 ) 3 —, — (CH 2 ) 4 —, — (CH 2 ) 6 —, — (CH 2 ) 8 —, — [CH 2 CH (CH 3 )] —, — (CH 2 ) 2 O (CH 2 ) 3 —, —CH 2 CH (OH) —CH 2 — and the like are mentioned, and preferably — (CH 2 ) 3 —. Propylene group.
なお、前記一般式(I)において、R1〜R7に見られる炭素数1〜8の1価有機基とは、アルキル基、シクロアルキル基、アリール基、アラルキル基、アルケニル基及びフッ化アルキル基から選ばれる炭素数1〜8の基を意味し、例えばメチル基、エチル基、プロピル基、ブチル基等のアルキル基;シクロペンチル基、シクロヘキシル基等のシクロアルキル基;フェニル基等のアリール基;ベンジル基等のアラルキル基;ビニル基、アリル基等のアルケニル基;3,3,3-トルフロロプロピル基等のフッ化アルキル基等を挙げることができる。 In the general formula (I), the monovalent organic group having 1 to 8 carbon atoms found in R 1 to R 7 is an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, an alkenyl group, and an alkyl fluoride. Means a group having 1 to 8 carbon atoms selected from a group, for example, an alkyl group such as a methyl group, an ethyl group, a propyl group and a butyl group; a cycloalkyl group such as a cyclopentyl group and a cyclohexyl group; an aryl group such as a phenyl group; An aralkyl group such as a benzyl group; an alkenyl group such as a vinyl group and an allyl group; a fluorinated alkyl group such as a 3,3,3-trifluoropropyl group, and the like.
また、R2、R3、R4はそれぞれ−OSiR5R6R7で示されるシロキシ基であってもよい。このようなシロキシ基としては、トリメチルシロキシ基、エチルジメチルシロキシ基、フェニルジメチルシロキシ基、ビニルジメチルシロキシ基、3,3,3-トリフルオロプロピルジメチルシロキシ基等が例示される。なおR1〜R7は、同一又は異なっていても良いが、本発明のシリコーン化多糖化合物においては、a=0で、R2、R3、R4がメチル基であることが特に好ましい。 R 2 , R 3 and R 4 may each be a siloxy group represented by —OSiR 5 R 6 R 7 . Examples of such a siloxy group include a trimethylsiloxy group, an ethyldimethylsiloxy group, a phenyldimethylsiloxy group, a vinyldimethylsiloxy group, and a 3,3,3-trifluoropropyldimethylsiloxy group. Note R 1 to R 7 may be the same or different, in the silicone-treated polysaccharide compound of the present invention, in a = 0, it is particularly preferable R 2, R 3, R 4 is a methyl group.
シリコーン化多糖化合物は、上記多糖化合物の有する反応性官能基(水酸基、カルボキシル基等)と、下記一般式(II)で示されるシリコーン化合物とを反応させることにより形成される。このようなシリコーン化合物と多糖化合物との反応には、公知の方法を用いることができる。
(化3)
上記一般式(II)中、Y、R1、R2、R3、R4及びaは前記一般式(I)と同じである。
また、Aは多糖化合物の有する反応性官能基と反応しうる官能基であり、例えば、イソシアネート基、エポキシ基、ビニル基、アクリロイル基、メタクリロイル基、アミノ基、イミノ基、水酸基、カルボキシル基、メルカプト基等が挙げられる。
The siliconized polysaccharide compound is formed by reacting a reactive functional group (hydroxyl group, carboxyl group, etc.) of the polysaccharide compound with a silicone compound represented by the following general formula (II). A known method can be used for the reaction between the silicone compound and the polysaccharide compound.
(Chemical formula 3)
In the general formula (II), Y, R 1 , R 2 , R 3 , R 4 and a are the same as those in the general formula (I).
A is a functional group capable of reacting with the reactive functional group of the polysaccharide compound. For example, isocyanate group, epoxy group, vinyl group, acryloyl group, methacryloyl group, amino group, imino group, hydroxyl group, carboxyl group, mercapto Groups and the like.
本発明において用いるシリコーン化多糖化合物として、特に好ましいものは下記式(III)で示されるシリコーン化プルランである。なお、式(III)中、PLはプルランのグルコース残基を表す。
(化4)
A particularly preferable silicone-modified polysaccharide compound used in the present invention is a silicone-treated pullulan represented by the following formula (III). In the formula (III), PL represents a glucose residue of pullulan.
(Chemical formula 4)
なお、本発明のシリコーン化多糖化合物において、多糖化合物の反応性官能基に対するシリコーン化合物の結合割合は、必ずしも100%である必要はないが、多糖化合物に対するシリコーン化合物の結合割合が低すぎると本発明の効果が十分に発揮されない。また、シリコーン化多糖化合物は、直鎖状あるいは環状の低分子量シリコーン油、又は軽質イソパラフィンに溶解して用いると、皮膚外用剤への配合しやすくなるとともに、ハリ感が良好になるので好ましい。従って、本発明においてシリコーン化多糖化合物は、直鎖状あるいは環状の低分子量シリコーン油、又は軽質イソパラフィンに溶解する程度にシリコーン化合物が結合していることが望ましい。具体的には、その種類によって異なるが、通常、多糖化合物の構成糖1単位当たりの、シリコーン化合物の平均結合数(置換度)が0.5〜2.5であることが好適である。なお、本発明において置換度は化合物中のSi含有量(質量%)から換算したものである。 In the silicone-modified polysaccharide compound of the present invention, the bonding ratio of the silicone compound to the reactive functional group of the polysaccharide compound is not necessarily 100%. However, if the bonding ratio of the silicone compound to the polysaccharide compound is too low, the present invention The effect of is not fully demonstrated. In addition, it is preferable to use the silicone-modified polysaccharide compound by dissolving it in a linear or cyclic low molecular weight silicone oil or light isoparaffin, since it can be easily blended into an external preparation for skin and a feeling of firmness is improved. Accordingly, in the present invention, it is desirable that the silicone compound is bound to such an extent that the silicone-modified polysaccharide compound is dissolved in a linear or cyclic low molecular weight silicone oil or light isoparaffin. Specifically, although it varies depending on the type, it is usually preferable that the average number of bonds (substitution degree) of the silicone compound per unit saccharide unit of the polysaccharide compound is 0.5 to 2.5. In the present invention, the degree of substitution is calculated from the Si content (% by mass) in the compound.
本発明の皮膚外用剤中、シリコーン化多糖化合物の配合量は皮膚外用剤の形態によって異なるが、0.01〜5.0質量%であることが好ましく、0.01〜3.0質量%であることが特に好ましい。0.01質量%未満では、十分なハリ感を付与することができず、5質量%を超えると皮膜にヨレが生じ、使用感を損なう傾向にある。 In the external preparation for skin of the present invention, the amount of the silicone-modified polysaccharide compound varies depending on the form of the external preparation for skin, but is preferably 0.01 to 5.0 mass%, preferably 0.01 to 3.0 mass%. It is particularly preferred. If the amount is less than 0.01% by mass, sufficient firmness cannot be imparted, and if it exceeds 5% by mass, the film tends to be twisted and the feeling of use tends to be impaired.
(b)無機複合粉体
本発明の無機複合粉体は、鱗片状基材上に、屈折率が互いに異なる2種以上の無機酸化物が屈折率の高いものから順次積層してなり、最外層とその内側の無機酸化物層との屈折率の差が0.6以下であることを特徴とするものである。
前記鱗片状基材は平均粒子径が2〜20μmで、厚みが0.05〜1μmであることが好ましい。このような鱗片状基材としては、マイカ、タルク、セリサイト等の天然鉱物、合成マイカ、合成タルク、合成セリサイト、板状酸化チタン、板状シリカ、板状酸化アルミニウム、ボロンナイトライド、板状硫酸バリウム、板状チタニア・シリカ複合酸化物等から選択される1種又は2種以上であることが好ましい。
(B) Inorganic composite powder The inorganic composite powder of the present invention is obtained by laminating two or more inorganic oxides having different refractive indexes on a scaly substrate in order from those having a high refractive index. And a difference in refractive index between the inorganic oxide layer and the inner inorganic oxide layer is 0.6 or less.
The scaly substrate preferably has an average particle diameter of 2 to 20 μm and a thickness of 0.05 to 1 μm. Such scaly substrates include natural minerals such as mica, talc and sericite, synthetic mica, synthetic talc, synthetic sericite, plate-like titanium oxide, plate-like silica, plate-like aluminum oxide, boron nitride, plate It is preferable that it is 1 type, or 2 or more types selected from plate-like barium sulfate, plate-like titania-silica composite oxide, and the like.
鱗片状基材に順次被覆される無機酸化物を屈折率と共に挙げれば、次の通りである。
酸化チタン(2.50)、酸化亜鉛(2.0)、酸化ジルコニウム(2.2)、酸化セリウム(2.2)、酸化スズ(2.0)、酸化タリウム(2.1)、チタン酸バリウム(2.4)、酸化アルミニウム(1.73)、酸化マグネシウム(1.77)、酸化イットリウム(1.92)、シリカ(1.45)、フッ化マグネシウム(1.38)、炭酸マグネシウム(1.5)、フッ化カルシウム(1.43)。
Examples of inorganic oxides sequentially coated on the scaly substrate together with the refractive index are as follows.
Titanium oxide (2.50), zinc oxide (2.0), zirconium oxide (2.2), cerium oxide (2.2), tin oxide (2.0), thallium oxide (2.1), titanic acid Barium (2.4), aluminum oxide (1.73), magnesium oxide (1.77), yttrium oxide (1.92), silica (1.45), magnesium fluoride (1.38), magnesium carbonate ( 1.5), calcium fluoride (1.43).
本発明に係る無機複合粉体は、前記無機酸化物から選択される2種以上の屈折率の異なる無機酸化物が屈折率の高い方から順に2層以上形成される。最外層に形成した無機酸化物とその内側層の無機酸化物との屈折率の差は0.6以下とすることが必要であり、特に好ましい範囲は、0.5〜0.05である。
本発明において、より一層光肌の透明感を演出するためには、全ての隣り合う層の屈折率の差を0.6以下、特に、0.5〜0.05とすることが望ましい。即ち、第2層として第1層の無機酸化物の屈折率との差が0.6以下の無機酸化物を選び、さらに必要に応じて形成される第3層以下も同様の選択を行うことが望ましい。
In the inorganic composite powder according to the present invention, two or more kinds of inorganic oxides having different refractive indexes selected from the inorganic oxides are formed in order from the higher refractive index. The difference in refractive index between the inorganic oxide formed in the outermost layer and the inorganic oxide in the inner layer must be 0.6 or less, and a particularly preferred range is 0.5 to 0.05.
In the present invention, in order to further enhance the transparency of the light skin, it is desirable that the difference in refractive index between all adjacent layers be 0.6 or less, particularly 0.5 to 0.05. That is, an inorganic oxide whose difference from the refractive index of the inorganic oxide of the first layer is 0.6 or less is selected as the second layer, and the same is selected for the third layer or less formed as necessary. Is desirable.
また、本発明に係る無機複合粉体は、各層間の屈折率の差が0.6以下でない場合であっても、第2層以下の各層のうち少なくとも1つの層の厚さが下記式で計算される値dの±20%の範囲にあればよい。これは、前記1つの層の下層に位置する層における反射光と、前記1つの層における反射光の位相が逆転し、光の干渉作用により光の反射が抑制され、透明感を有するようになるからである。
式: d=(λ×X/4)/n
(但し、上記式において、λ:可視光の波長、X:奇数である整数、n:無機酸化物の屈折率である。)
また、好みの色調、色彩等の化粧料の使用目的や、昼間、夜間、照明、衣装の色等の使用環境に応じて、反射すべき波長、反射を弱めるべき波長を考慮して上記式に用いる可視光の波長を選択することができ、且つ、層の厚さを調整することができる。
奇数である整数Xの値としては、層の厚さを薄くできる等の理由から、通常は1を用いるのが好ましい。例えば、酸化チタンの層の上に酸化アルミニウムを被覆する場合、λ=550nm、n=1.73であるから、酸化アルミニウムの層の厚さは約80nmとなる。
In addition, the inorganic composite powder according to the present invention has a thickness of at least one layer among the layers below the second layer even when the difference in refractive index between the layers is not less than 0.6. It may be within a range of ± 20% of the calculated value d. This is because the phase of the reflected light in the layer located below the one layer and the reflected light in the one layer are reversed, the reflection of light is suppressed by the light interference action, and it has a sense of transparency. Because.
Formula: d = (λ × X / 4) / n
(In the above formula, λ is the wavelength of visible light, X is an integer that is an odd number, and n is the refractive index of the inorganic oxide.)
In addition, according to the usage purpose of cosmetics such as the desired color tone and color, and the usage environment such as daytime, nighttime, lighting, clothing color, etc. The wavelength of visible light to be used can be selected, and the thickness of the layer can be adjusted.
As the value of the integer X which is an odd number, it is usually preferable to use 1 for the reason that the thickness of the layer can be reduced. For example, when aluminum oxide is coated on a titanium oxide layer, since λ = 550 nm and n = 1.73, the thickness of the aluminum oxide layer is about 80 nm.
特に、無機複合粉体の最外層に屈折率が1.5以下、特に、1.5〜1.35の無機酸化物を形成しておくことが好ましい。最外層として特に好ましい無機酸化物は、シリカである。
より好ましくは、タルクあるいはセリサイトの上に酸化チタン、酸化アルミニウム、シリカを順次被覆した複合粉末であることが好ましい。市販原料としては、例えば、カバーリーフAR-80TM(タルクに酸化チタン、酸化アルミニウム、シリカを順に被覆したもの;図1参照)、カバーリーフAR-20121MTM(セリサイトに酸化チタン、酸化アルミニウム、シリカを順に被覆したもの)(触媒化成工業社製)等が挙げられる。
In particular, it is preferable to form an inorganic oxide having a refractive index of 1.5 or less, particularly 1.5 to 1.35, in the outermost layer of the inorganic composite powder. A particularly preferred inorganic oxide for the outermost layer is silica.
More preferably, it is a composite powder in which talc or sericite is sequentially coated with titanium oxide, aluminum oxide, and silica. Commercially available materials include, for example, Coverleaf AR-80 ™ (talc coated with titanium oxide, aluminum oxide, and silica in order; see FIG. 1), Coverleaf AR-20121M ™ (Sericite with titanium oxide, aluminum oxide, And silica coated in order) (manufactured by Catalyst Kasei Kogyo Co., Ltd.).
無機酸化物の被覆方法としては、無機酸化物の前駆物質である金属塩を所定量加水分解し、あるいは、同様に所定量の有機金属化合物をアルコール溶媒中で加水分解し、加水分解物を基材あるいは被覆層を形成した基材上に析出させる方法など、従来公知の方法が採用できる。
例えば、鱗片状基材を水中に分散させ、これに所定量の硫酸チタニルなどの金属塩を添加し、アルカリ雰囲気で加水分解し、鱗片状基材表面に金属塩加水分解物を析出させることにより、所定厚の酸化チタン被覆層を得ることができる。
また、最外層としてシリカを被覆する場合には、シリカより高い屈折率の被覆層を形成した鱗片状基材の分散液に所定量のアルカリ金属珪酸塩水溶液あるいは有機珪素化合物等を添加し、必要に応じて酸またはアルカリを加えて被覆層形成鱗片状基材表面に珪酸の重合物(加水分解縮重合物)を付着させる等の方法により、所定の厚みのシリカ被覆層を形成することができる。なお、シリカの被覆層を形成するには、他の従来法を採用することもできる。
As a method for coating the inorganic oxide, a predetermined amount of a metal salt that is a precursor of the inorganic oxide is hydrolyzed, or similarly, a predetermined amount of an organometallic compound is hydrolyzed in an alcohol solvent, and the hydrolyzate is used as a base. A conventionally known method such as a method of depositing on a material or a base material on which a coating layer is formed can be employed.
For example, by dispersing a flaky substrate in water, adding a predetermined amount of a metal salt such as titanyl sulfate, hydrolyzing in an alkaline atmosphere, and depositing a metal salt hydrolyzate on the surface of the flaky substrate A titanium oxide coating layer having a predetermined thickness can be obtained.
In addition, when silica is coated as the outermost layer, a predetermined amount of an alkali metal silicate aqueous solution or an organic silicon compound is added to the dispersion of a scale-like substrate on which a coating layer having a refractive index higher than that of silica is added. Depending on the method, a silica coating layer having a predetermined thickness can be formed by a method such as adding an acid or an alkali to attach a polymer of silicic acid (hydrolysis condensation polymer) to the surface of the scale-like substrate. . In order to form a silica coating layer, other conventional methods may be employed.
本発明おいて、無機酸化物の被覆膜厚は、鱗片状基材あるいは無機酸化物を被覆した鱗片状基材の幾何学的表面積あるいは窒素吸着法等で測定される比表面積と被覆する無機酸化物の密度より求めることができる。また、所定の膜厚となる金属酸化物の量から添加する所定量の金属塩、有機金属化合物を計算することができる。 In the present invention, the coating thickness of the inorganic oxide is determined by the geometric surface area of the scaly substrate or the scaly substrate coated with the inorganic oxide or the specific surface area measured by the nitrogen adsorption method or the like. It can be determined from the density of the oxide. Further, a predetermined amount of metal salt or organometallic compound to be added can be calculated from the amount of metal oxide having a predetermined film thickness.
全無機酸化物の被覆量は特に限定されないが、鱗片状基材100重量部に対し1〜70重量部の範囲にあることが好ましく、更に好ましくは5〜50重量部の範囲である。1重量部未満では充分な美肌演出効果、べたつき軽減効果が得られにくく、70重量部を超えると不自然な仕上がりとなったり、感触が悪くなったりする傾向がある。
なお、本発明の無機複合粉体は、その表面をシリコーンやフッ素化合物等で処理して用いてもよい。
The coating amount of the total inorganic oxide is not particularly limited, but is preferably in the range of 1 to 70 parts by weight, more preferably in the range of 5 to 50 parts by weight with respect to 100 parts by weight of the scaly substrate. If it is less than 1 part by weight, it is difficult to obtain a sufficient skin effect and stickiness reduction effect, and if it exceeds 70 parts by weight, it tends to have an unnatural finish or a poor feel.
The inorganic composite powder of the present invention may be used by treating the surface with silicone, a fluorine compound or the like.
本発明の皮膚外用剤において前記無機複合粉体の配合量は0.1〜20質量%が好ましく、1.0〜5.0質量%であることが特に好ましい。0.1質量%未満では十分なべたつき軽減効果、美肌演出効果が得られず、20質量%を越えると塗布後の皮膚の外観を損なう傾向にあり、また粉末に起因するヨレが起こる傾向にある。
本発明の皮膚外用剤は、前記シリコーン化多糖化合物と、前記無機複合粉体とを組み合わせて配合することにより、皮膚化粧料を塗布した際、粉末を肌上に平たく均一に配向させることができ、肌にハリ感を付与する。また、前記シリコーン化多糖化合物に起因するべたつきが軽減される。さらに透明感があってしかも肌の欠点を隠すことができ、美肌演出効果に優れたものとなる。
In the external preparation for skin of the present invention, the blending amount of the inorganic composite powder is preferably 0.1 to 20% by mass, and particularly preferably 1.0 to 5.0% by mass. If the amount is less than 0.1% by mass, sufficient stickiness reduction effect and beautiful skin directing effect cannot be obtained. .
The external preparation for skin of the present invention can be uniformly and uniformly oriented on the skin when a skin cosmetic is applied by combining the silicone-modified polysaccharide compound and the inorganic composite powder. Gives skin firmness. Moreover, the stickiness resulting from the silicone-modified polysaccharide compound is reduced. Furthermore, there is a sense of transparency, and it is possible to hide the skin defects, and it is excellent in the effect of producing beautiful skin.
(c)架橋型ポリメチルシロキサン
本発明において、さらに架橋型ポリメチルシロキサンを配合することにより、塗布時のよれを軽減し、サラサラとした感触を付与することができる。
本発明において用いられる架橋型ポリメチルシロキサンとは、オルガノハイドロジェンシロキサンとビニルジメチルシロキサンを架橋反応させたINCI名ジメチコン/ビニルジメチコンクロスポリマーあるいはポリシリコーン−11と称されるもの;オルガノハイドロジェンシロキサンとアルケンを架橋反応させたINCI名ジメチコンクロスポリマーと称されるもの;ラウリルオリガノハイドロジェンシロキサンとビニルジメチルシロキサンを架橋反応させたINCI名ビニルジメチコン/ラウリルジメチコンクロスポリマーと称されるものが該当する。
また、架橋型ポリメチルシロキサンは、低粘度油、特に直鎖状あるいは環状のシリコーン油により膨潤している状態で配合することが好ましい。
本発明に用いられる架橋型ポリメチルシロキサンの低粘度油への膨潤物の市販品としては、以下のようなものが挙げられ、入手して使用することができる。
ジメチコン/ビニルジメチコンクロスポリマーあるいはポリシリコーン−11と称されるものの膨潤物としては、信越化学工業(株)社製のKSG−15TM((ジメチコン/ビニルジメチコン)クロスポリマー,シクロペンタシロキサンの混合物で架橋物は約5%);KSG−16TM((ジメチコン/ビニルジメチコン)クロスポリマー,ジメチコン6mPa・sの混合物で架橋物は約25%);KSG−18TM((ジメチコン/ビニルジメチコン)クロスポリマー,フェニルトリメチコンの混合物で架橋物は約15%);KSG−41((ビニルジメチコン/ラウリルジメチコン)クロスポリマー,流動パラフィンの混合物で架橋物は約30%);KSG−42TM((ビニルジメチコン/ラウリルジメチコン)クロスポリマー,軽質イソパラフィンの混合物で架橋物は約25%);KSG−43TM((ビニルジメチコン/ラウリルジメチコン)クロスポリマー,トリ2−エチルヘキサン酸グリセリルの混合物で架橋物は約30%);KSG−44TM((ビニルジメチコン/ラウリルジメチコン)クロスポリマー,スクワランの混合物で架橋物は約5%)や、東レ・ダウコーニング(株)社製のDC9040TM(ジメチコンクロスポリマー,デカメチルシクロペンタシロキサンの混合物で架橋物は12%);DC9041TM(ジメチコンクロスポリマー,ジメチコン5mPa・sの混合物で架橋物は16%);DC9045TM(ジメチコンクロスポリマー,デカメチルシクロペンタシロキサンの混合物で架橋物は12.5%)や、GRANT社のGRANSIL GCMTM(ポリシリコーン−11とオクタメチルシクロテトラシロキサンの混合物で架橋物は約6%);GRANSIL GCM−5TM(ポリシリコーン−11とデカメチルシクロペンタシロキサンの混合物で架橋物は約6%);GRANSIL IDSTM(ポリシリコーン−11とイソデカンの混合物で架橋物は約7%);GRANSIL DMG−6TM(ポリシリコーン−11とジメチコン6mPa・sの混合物で架橋物は約18%);GRANSIL DMG−20TM(ポリシリコーン−11とジメチコン20mPa・sの混合物で架橋物は約25%);GRANSIL DMG−50TM(ポリシリコーン−11とジメチコン50mPa・sの混合物で架橋物は約26%);GRANSIL PMTM(ポリシリコーン−11とフェニルトリメチコンの混合物で架橋物は約20%)、GRANSIL ININTM(ポリシリコーン−11とイソノナン酸イソノニルの混合物で架橋物は約15%)等が挙げられる。
(C) Crosslinkable polymethylsiloxane In the present invention, by further blending the crosslinkable polymethylsiloxane, the twist during application can be reduced and a smooth feel can be imparted.
The cross-linked polymethylsiloxane used in the present invention is an INCI name dimethicone / vinyl dimethicone crosspolymer obtained by cross-linking reaction of an organohydrogensiloxane and vinyldimethylsiloxane, or a poly-silicone-11; Examples include those referred to as INCI name dimethicone crosspolymers obtained by cross-linking alkene; those referred to as INCI name vinyl dimethicone / lauryl dimethicone cross polymers obtained by cross-linking lauryl origanohydrogensiloxane and vinyldimethylsiloxane.
The crosslinked polymethylsiloxane is preferably blended in a state where it is swollen with a low-viscosity oil, particularly a linear or cyclic silicone oil.
Examples of commercially available products of the swelling product of the crosslinked polymethylsiloxane used in the present invention into a low-viscosity oil include the following, which can be obtained and used.
As a swelling product of what is called dimethicone / vinyl dimethicone crosspolymer or polysilicone-11, a mixture of KSG-15 ™ ((dimethicone / vinyl dimethicone) crosspolymer and cyclopentasiloxane manufactured by Shin-Etsu Chemical Co., Ltd. is used. Crosslinked product is about 5%); KSG-16 ™ ((dimethicone / vinyl dimethicone) crosspolymer, dimethicone is 6 mPa · s, and the crosslinked product is about 25%); KSG-18 ™ ((dimethicone / vinyl dimethicone) crosspolymer KSG-41 ((vinyl dimethicone / lauryl dimethicone) crosspolymer, liquid paraffin mixture, about 30% crosslinked); KSG-42 ™ ((vinyl dimethicone) / Lauryl dimethicone) cross polymer , Cross-linked product with a mixture of light isoparaffin is about 25%); KSG-43 TM (( vinyl dimethicone / lauryl dimethicone) crosspolymer, a crosslinked product of a mixture of glyceryl tri-2-ethylhexanoate was about 30%); KSG-44 TM ((vinyl dimethicone / lauryl dimethicone) cross polymer, squalane mixture is about 5% crosslinked) and DC9040 TM (dimethicone cross polymer, decamethylcyclopentasiloxane mixture made by Toray Dow Corning Co., Ltd.) DC9041 ™ (dimethicone crosspolymer, mixture of dimethicone 5 mPa · s and 16% of crosslinked product); DC9045 ™ (dimethicone crosspolymer, mixture of decamethylcyclopentasiloxane and 12.5% of crosslinked product) ) Or GRANT G ANSIL GCM TM (crosslinked product of a mixture of polysilicone -11 and octamethylcyclotetrasiloxane about 6%); GRANSIL GCM-5 TM ( polysilicone -11 and mixtures crosslinked product of decamethylcyclopentasiloxane about 6% ); GRANSIL IDS ™ (polysilicone-11 and isodecane mixture is about 7% crosslinked); GRANSIL DMG-6 ™ (polysilicone-11 and dimethicone 6 mPa · s mixture is about 18% crosslinked); GRANSIL DMG-20 ™ (Polysilicone-11 and dimethicone 20 mPa · s mixture is about 25% crosslinked); GRANSIL DMG-50 ™ (Polysilicone-11 and dimethicone 50 mPa · s mixture is about 26% crosslinked) GRANSIL PM TM (Poly And a mixture of silicone-11 and phenyltrimethicone is about 20%), GRANSIL ININ ™ (a mixture of poly-silicone-11 and isononyl isononanoate is about 15%).
上記架橋型ポリメチルシロキサンは、皮膚外用剤全量中0.01〜10質量%配合することが好ましく、より好ましくは1.0〜5.0質量%である。0.01質量%未満では、組成物の十分な効果が得られないことがあり、10質量%を越えて配合すると使用感を損なう傾向にある。 The cross-linked polymethylsiloxane is preferably blended in an amount of 0.01 to 10 mass%, more preferably 1.0 to 5.0 mass%, based on the total amount of the external preparation for skin. If it is less than 0.01% by mass, sufficient effects of the composition may not be obtained, and if it exceeds 10% by mass, the feeling of use tends to be impaired.
本発明の皮膚外用剤は上記の必須成分を既存の皮膚外用剤基剤に配合することにより調製される。本発明の皮膚外用剤には上記した必須構成成分の他に本発明の効果を損なわない範囲において、通常化粧品や医薬品等の皮膚外用剤に用いられる他の成分、例えば、粉末成分、液体油脂、固体油脂、ロウ、炭化水素、高級脂肪酸、高級アルコール、エステル、シリコーン、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、非イオン界面活性剤、保湿剤、水溶性高分子、増粘剤、皮膜剤、紫外線吸収剤、金属イオン封鎖剤、低級アルコール、多価アルコール、糖、アミノ酸、有機アミン、高分子エマルジョン、pH調整剤、皮膚栄養剤、ビタミン、酸化防止剤、酸化防止助剤、香料、水等を必要に応じて適宜配合し、目的とする剤形に応じて常法により製造することが出来る。 The skin external preparation of this invention is prepared by mix | blending said essential component with the existing skin external preparation base. In addition to the essential components described above, the external preparation for skin of the present invention is not limited to the effects of the present invention, and other components usually used in external preparations for skin such as cosmetics and pharmaceuticals, for example, powder components, liquid fats and oils, Solid fats, waxes, hydrocarbons, higher fatty acids, higher alcohols, esters, silicones, anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, humectants, water-soluble polymers, thickeners , Film agent, ultraviolet absorber, sequestering agent, lower alcohol, polyhydric alcohol, sugar, amino acid, organic amine, polymer emulsion, pH adjuster, skin nutrient, vitamin, antioxidant, antioxidant aid, A fragrance, water and the like can be appropriately blended as necessary, and can be produced by a conventional method according to the intended dosage form.
その他の配合可能成分としては、例えば、防腐剤(エチルパラベン、ブチルパラベン等);消炎剤(例えば、グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等);美白剤(例えば、胎盤抽出物、ユキノシタ抽出物、アルブチン、コウジ酸、ビタミンC、アスコルビン酸リン酸マグネシウム、アスコルビン酸グルコシド等);各種抽出物(例えば、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等)、賦活剤(例えば、ローヤルゼリー、感光素、コレステロール誘導体等);血行促進剤(例えば、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β−ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、タンニン酸、α−ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ−オリザノール等);抗脂漏剤(例えば、硫黄、チアントール等);抗炎症剤(例えば、トラネキサム酸、チオタウリン、ヒポタウリン等)等が挙げられる。 Other components that can be blended include, for example, preservatives (ethyl paraben, butyl paraben, etc.); anti-inflammatory agents (eg, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc.); whitening agents (for example, , Placenta extract, yukinoshita extract, arbutin, kojic acid, vitamin C, magnesium ascorbate phosphate, glucoside ascorbate, etc .; various extracts (eg, alum, auren, shikon, peonies, assembly, birch, sage, loquat) , Carrot, aloe, mallow, iris, grape, yokoinin, loofah, lily, saffron, senkyu, ginger, hypericum, onionis, garlic, pepper, chimney, red snapper, seaweed, etc.), activator (e.g. royal jelly, photosensitizer, A blood circulation promoter (eg, nonyl acid valenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, gingerone, cantalis tincture, ictamol, tannic acid, α-borneol, nicotinic acid tocopherol, inositol Hexanicotinate, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, γ-oryzanol, etc.); antiseborrheic agent (eg, sulfur, thianthol, etc.); ) And the like.
本発明の皮膚外用剤は、外皮に適用される化粧料、医薬品、及び医薬部外品に広く適用することが可能である。その剤型は任意であり、溶液系、可溶化系、乳化系、粉末分散系、水-油二層系、水-油-粉末三層系、ゲル、エアゾール、ミスト、及びカプセル等、任意の形態で提供されることができる。また、本発明の皮膚外用剤の製品形態も任意であり、化粧水、乳液、クリーム、パック等のフェイシャル化粧料;ファンデーション、おしろい、頬紅、口紅、アイシャドー、アイライナー、マスカラ、サンスクリーン等のメーキャップ化粧料;ボディー化粧料;芳香化粧料;メーク落とし、洗顔料、ボディーシャンプー等の皮膚洗浄料;ヘアーリンス、シャンプー等の毛髪化粧料;軟膏;浴用剤;あぶら取り紙等、従来皮膚外用剤に用いるものであればいずれの形で適用することもできる。 The external preparation for skin of the present invention can be widely applied to cosmetics, pharmaceuticals, and quasi drugs applied to the outer skin. The dosage form is arbitrary, such as solution system, solubilization system, emulsification system, powder dispersion system, water-oil two-layer system, water-oil-powder three-layer system, gel, aerosol, mist, capsule, etc. It can be provided in the form. Further, the product form of the external preparation for skin of the present invention is arbitrary, and facial cosmetics such as skin lotion, emulsion, cream, pack, etc .; foundations, funny, blusher, lipstick, eye shadow, eyeliner, mascara, sunscreen, etc. Makeup cosmetics; body cosmetics; aromatic cosmetics; skin cleansers such as make-up removers, facial cleansers, body shampoos; hair cosmetics such as hair rinses and shampoos; ointments; bath preparations; It can be applied in any form as long as it is used.
以下、実施例を挙げて本発明をさらに詳しく説明する。本発明はこれらの実施例により限定されるものではない。配合量については特に断りのない限り質量%を示す。
実施例に先立ち、本発明で用いた評価方法を説明する。
(1)べたつき
女性パネラー20名の上腕部に被験試料を手で塗布し、塗布後のべたつきについてアンケートを行い、以下の基準で評価した。
◎:べたつきやぬめりがないと答えたパネラーが16名以上。
○:べたつきやぬめりがないと答えたパネラーが12〜15名。
△:べたつきやぬめりがないと答えたパネラーが8〜11名。
×:べたつきやぬめりがないと答えたパネラーが7名以下。
Hereinafter, the present invention will be described in more detail with reference to examples. The present invention is not limited to these examples. Unless otherwise specified, the blending amount indicates mass%.
Prior to the examples, the evaluation method used in the present invention will be described.
(1) Stickiness The test sample was applied by hand to the upper arms of 20 female panelists, a questionnaire about stickiness after application was conducted, and the following criteria were evaluated.
A: More than 16 panelists answered that there was no stickiness or sliminess.
○: 12 to 15 panelists answered that there was no stickiness or sliminess.
Δ: 8 to 11 panelists who answered that there was no stickiness or sliminess.
×: Seven or fewer panelists answered that there was no stickiness or sliminess.
(2)はり感
女性パネラー20名の上腕部に被験試料を手で塗布し、塗布後の肌のはり感についてアンケートを行い、以下の基準で評価した。
◎:塗布後の肌に、はりがあると答えたパネラーが16名以上。
○:塗布後の肌に、はりがあると答えたパネラーが12〜15名。
△:塗布後の肌に、はりがあると答えたパネラーが8〜11名。
×:塗布後の肌に、はりがあると答えたパネラーが7名以下。
(2) Feeling feeling The test sample was applied by hand to the upper arms of 20 female panelists, and a questionnaire was conducted on the feeling of stickiness of the skin after application, and the following criteria were used.
A: More than 16 panelists answered that there was a beam on the skin after application.
○: 12 to 15 panelists answered that the skin after application had a beam.
Δ: There were 8 to 11 panelists who answered that there was a beam on the skin after application.
×: Seven or fewer panelists answered that there was a beam on the skin after application.
(3)よれ
女性パネラー20名の上腕部に被験試料を手で塗布し、塗布後の粉末のよれについてアンケートを行い、以下の基準で評価した。
◎:粉末のよれがないと答えたパネラーが16名以上。
○:粉末のよれがないと答えたパネラーが12〜15名。
△:粉末のよれがないと答えたパネラーが8〜11名。
×:粉末のよれがないと答えたパネラーが7名以下。
(3) Shaft A test sample was manually applied to the upper arm of 20 female panelists, a questionnaire was conducted on the warp of the powder after application, and the following criteria were evaluated.
A: More than 16 panelists answered that there was no powder distortion.
○: There are 12 to 15 panelists who answered that the powder was not warped.
Δ: There are 8 to 11 panelists who answered that there was no powder sag.
×: Seven or fewer panelists answered that there was no powder distortion.
(4)馴染み、伸び
女性パネラー20名の上腕部に被験試料を手で塗布し、塗布時の馴染み、伸びについてアンケートを行い、以下の基準で評価した。
◎:塗布時、馴染み、伸びが良いと答えたパネラーが16名以上。
○:塗布時、馴染み、伸びが良いと答えたパネラーが12〜15名。
△:塗布時、馴染み、伸びが良いと答えたパネラーが8〜11名。
×:塗布時、馴染み、伸びが良いと答えたパネラーが7名以下。
(4) Familiarity and Elongation Test samples were applied by hand to the upper arms of 20 female panelists, a questionnaire was conducted on familiarity and elongation during application, and evaluation was performed according to the following criteria.
A: More than 16 panelists answered that they were familiar and stretched well when applied.
○: 12 to 15 panelists answered that they were familiar and good in stretching.
Δ: 8 to 11 panelists answered that they were familiar and stretched well during application.
X: Seven or fewer panelists answered that they were familiar and stretched well during application.
(5)製剤安定性
試料を−20℃に一週間保存した後、室温に戻して状態を観察した。
○:異常なし
△:わずかに粉末の凝集が見られる。
×:粉末の凝集が見られる。
(5) Formulation stability After storing a sample at -20 degreeC for one week, it returned to room temperature and observed the state.
○: No abnormality Δ: Slight aggregation of powder is observed.
X: Agglomeration of powder is observed.
(6)色ムラ・凹凸ぼかし効果
女性パネラー20名の顔面に被験試料を手で塗布し、色ムラ・凹凸ぼかし効果があるかどうかについてアンケートを行い、以下の基準で評価した。
◎:色ムラ・凹凸ぼかし効果があると答えたパネラーが16名以上。
○:色ムラ・凹凸ぼかし効果があると答えたパネラーが12〜15名。
△:色ムラ・凹凸ぼかし効果があると答えたパネラーが8〜11名。
×:色ムラ・凹凸ぼかし効果があると答えたパネラーが7名以下。
(6) Color unevenness and uneven blurring effect The test sample was applied by hand to the faces of 20 female panelists, and a questionnaire was conducted to determine whether there was an effect of color unevenness and uneven unevenness.
A: More than 16 panelists answered that there was an uneven color and uneven blurring effect.
○: There are 12 to 15 panelists who answered that there was a color unevenness / unevenness blur effect.
Δ: There are 8 to 11 panelists who answered that there was a color unevenness / unevenness blurring effect.
×: Seven or fewer panelists answered that there was a color unevenness / unevenness blurring effect.
(7)透明感
女性パネラー20名の顔面に被験試料を手で塗布し、仕上がりに透明感があるかどうかについてアンケートを行い、以下の基準で評価した。
◎:透明感があると答えたパネラーが16名以上。
○:透明感があると答えたパネラーが12〜15名。
△:透明感があると答えたパネラーが8〜11名。
×:透明感があると答えたパネラーが7名以下。
(7) Transparency A test sample was applied by hand to the faces of 20 female panelists, and a questionnaire was conducted to determine whether the finish was transparent. Evaluation was made according to the following criteria.
A: More than 16 panelists answered that there was a sense of transparency.
○: 12 to 15 panelists answered that there was a sense of transparency.
Δ: There are 8 to 11 panelists who answered that there was transparency.
×: Seven or fewer panelists answered that there was a sense of transparency.
(表1)
(*1)3−[トリス(トリメチルシロキシ)シリル]プロピルカルバミド酸プルラン
(*2)カバーリーフAR−80TM(触媒化成工業(株)製)
(*3)サンスフェアーL51TM(旭硝子社製)
(*4)エラストマーブレンドDC9041TM(ダウコーニング社製)
(Table 1)
(* 1) 3- [Tris (trimethylsiloxy) silyl] propylcarbamic acid pullulan (* 2) Coverleaf AR-80 ™ (manufactured by Catalyst Kasei Kogyo Co., Ltd.)
(* 3) Sunsphere L51 TM (Asahi Glass Co., Ltd.)
(* 4) Elastomer blend DC9041 ™ (Dow Corning)
表1からわかるように、皮膜剤として頻繁に使用されるトリメチルシロキシケイ酸と、タルクを組み合わせた場合(試験例3)には、はり感が得られず、べたつき、よれが起こり、製剤安定性が悪く、馴染みや伸びの点でも好ましくない。また、色ムラ・凹凸ぼかし効果や透明感も得られなかった。
また、シリコーン化多糖とタルクとを組み合わせた場合(試験例4)、あるいはシリコーン化多糖と多孔質シリカとを組み合わせた場合(試験例5)も、べたつきやハリ感、透明感が多少改善されたものの十分ではなく、よれや製剤安定性の改善は見られなかった。
シリコーン化多糖と従来の無機複合粉体(シリカ被覆タルク)を組み合わせた場合(試験例6)も同様であった。
一方、皮膜剤として頻繁に使用されるトリメチルシロキシケイ酸と、本発明の無機複合粉体との組合せ(試験例7)においても、よれが起こるなどの欠点を有し、使用感、美肌演出効果ともに、十分ではなかった。
これに対し、試験例1から分かるように、シリコーン化多糖と本発明の無機複合粉体とを組み合わせることにより、べたつきを生じず良好なハリ感を有し、しかも美肌演出効果に優れたものとなった。
さらに試験例2から分かるように、架橋型ポリメチルシロキサンを組み合わせることにより、製剤安定性を損なうことなく、べたつきをさらに効果的に抑えられ、色ムラ・凹凸ぼかし効果の点でもさらに改良されることがわかった。
As can be seen from Table 1, when trimethylsiloxysilicic acid, which is frequently used as a coating agent, and talc are combined (Test Example 3), no stickiness is obtained, stickiness and kinking occur, and formulation stability However, it is not preferable in terms of familiarity and elongation. In addition, color unevenness, uneven blurring effect and transparency were not obtained.
In addition, when silicone-modified polysaccharide and talc were combined (Test Example 4), or when silicone-modified polysaccharide and porous silica were combined (Test Example 5), stickiness, firmness, and transparency were slightly improved. However, it was not sufficient, and no improvement in kink and formulation stability was observed.
The same was true when the silicone-modified polysaccharide and the conventional inorganic composite powder (silica-coated talc) were combined (Test Example 6).
On the other hand, the combination of the trimethylsiloxysilicic acid frequently used as a film agent and the inorganic composite powder of the present invention (Test Example 7) also has drawbacks such as kinking, and has a feeling of use and a beautiful skin effect. Both were not enough.
On the other hand, as can be seen from Test Example 1, by combining the silicone-modified polysaccharide and the inorganic composite powder of the present invention, it has a good elasticity without causing stickiness, and is excellent in the effect of producing beautiful skin. became.
Furthermore, as can be seen from Test Example 2, by combining the cross-linked polymethylsiloxane, stickiness can be more effectively suppressed without impairing the stability of the preparation, and further improved in terms of uneven color and uneven blurring effect. I understood.
次にシリコーン化多糖と無機複合粉体の好適な配合量を検討した。
(表2)
Next, the suitable compounding quantity of silicone-ized polysaccharide and inorganic composite powder was examined.
(Table 2)
表2より、シリコーン化多糖の添加効果は0.01質量%から発揮され、配合量は0.01〜5.0質量%、特に0.01〜3.0質量%であることが好ましいことが確認された。
また、無機複合粉体の添加効果は0.1質量%から発揮され、配合量は0.1〜20質量%が好ましく、1.0〜5.0質量%であることが特に好ましいことが確認された。
なお、本発明者らがさらに検討したところ、架橋型ポリメチルシロキサンの添加効果は、0.01質量%から発揮され、配合量は0.01〜10質量%であることが好ましく、より好ましくは1.0〜5.0質量%であることが確認された。
From Table 2, the effect of adding the silicone-modified polysaccharide is exhibited from 0.01% by mass, and the blending amount is preferably 0.01 to 5.0% by mass, and particularly preferably 0.01 to 3.0% by mass. confirmed.
The addition effect of the inorganic composite powder is exhibited from 0.1% by mass, and the blending amount is preferably 0.1 to 20% by mass, and particularly preferably 1.0 to 5.0% by mass. It was done.
In addition, when the present inventors further examined, the addition effect of the cross-linked polymethylsiloxane is exhibited from 0.01% by mass, and the blending amount is preferably 0.01 to 10% by mass, more preferably It was confirmed to be 1.0 to 5.0% by mass.
本発明にかかる皮膚外用剤の好適な実施例を以下に示すが、これに限定されない。いずれの実施例においても、べたつきを生じず良好なハリ感を有し、しかも美肌演出効果に優れた皮膚外用剤が得られた。
実施例1 O/Wクリーム
処方 (質量%)
(1)流動パラフィン 3.0
(2)ワセリン 1.0
(3)ジメチルポリシロキサン 1.0
(4)ステアリルアルコール 1.8
(5)ベヘニルアルコール 1.6
(6)マカデミアナッツ油 2.0
(7)パーム硬化油 3.0
(8)スクワラン 6.0
(9)ステアリン酸 2.0
(10)ヒドロキシステアリン酸コレステリル 0.5
(11)2−エチルヘキサン酸セチル 4.0
(12)ポリオキシエチレン硬化ヒマシ油 0.5
(13)自己乳化型モノステアリン酸グリセリン 3.0
(14)酢酸トコフェロール 0.1
(15)レチノール 0.01
(16)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物 5.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(17)4-t-ブチル-4'-メトキシジベンゾイルメタン 0.05
(18)パラオキシ安息香酸エステル 適量
(19)ジパラメトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリル 0.05
(20)水酸化カリウム 0.15
(21)ヘキサメタリン酸ナトリウム 0.05
(22)トリメチルグリシン 2.0
(23)グリセリン 8.0
(24)ジプロピレングリコール 5.0
(25)α-トコフェロール2-L-アスコルビン酸リン酸ジエステルカリウム 1.0
(26)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.1
(Aristoflex AVCTM;Clariant社製)
(27)甜茶エキス 0.1
(28)酵母エキス 0.1
(29)エデト酸3ナトリウム 0.05
(30)カルボキシビニルポリマー 0.05
(31)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(32)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 10.0
(33)雲母チタン 0.1
(34)色剤 適量
(35)精製水 残余
Although the suitable Example of the external preparation for skin concerning this invention is shown below, it is not limited to this. In any of the examples, an external preparation for skin was obtained that did not cause stickiness, had a good firmness, and was excellent in the effect of producing beautiful skin.
Example 1 O / W cream formulation (mass%)
(1) Liquid paraffin 3.0
(2) Vaseline 1.0
(3) Dimethylpolysiloxane 1.0
(4) Stearyl alcohol 1.8
(5) Behenyl alcohol 1.6
(6) Macadamia nut oil 2.0
(7) Hardened palm oil 3.0
(8) Squalane 6.0
(9) Stearic acid 2.0
(10) cholesteryl hydroxy stearate 0.5
(11) Cetyl 2-ethylhexanoate 4.0
(12) Polyoxyethylene hydrogenated castor oil 0.5
(13) Self-emulsifying glyceryl monostearate 3.0
(14) Tocopherol acetate 0.1
(15) Retinol 0.01
(16) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(17) 4-t-Butyl-4'-methoxydibenzoylmethane 0.05
(18) paraoxybenzoic acid ester appropriate amount
(19) Diparamethoxycinnamate mono-2-ethylhexanoate glyceryl 0.05
(20) Potassium hydroxide 0.15
(21) Sodium hexametaphosphate 0.05
(22) Trimethylglycine 2.0
(23) Glycerin 8.0
(24) Dipropylene glycol 5.0
(25) α-Tocopherol 2-L-ascorbic acid phosphate diester potassium 1.0
(26) (Acroyldimethyltauronium ammonium / VP) copolymer 0.1
(Aristoflex AVC TM ; manufactured by Clariant)
(27) Green tea extract 0.1
(28) Yeast extract 0.1
(29) edetate trisodium 0.05
(30) Carboxyvinyl polymer 0.05
(31) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 1.0
(32) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 10.0
(33) Titanium mica 0.1
(34) Coloring agent appropriate amount
(35) Purified water residue
実施例2 はり対応W/Oクリーム
処方 (質量%)
(1)ジメチルポリシロキサン 3.0
(2)デカメチルシクロペンタシロキサン 13.0
(3)ドデカメチルシクロヘキサシロキサン 5.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 1.0
(5)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(6)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物 5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(7)酢酸レチノール 0.1
(8)パラオキシ安息香酸エステル 適量
(9)L−メントール 適量
(10)トリメチルシロキシケイ酸 2.0
(11)エタノール 2.0
(12)グリセリン 3.0
(13)ジプロピレングリコール 5.0
(14)ポリエチレングリコール6000 5.0
(15)ヘキサメタリン酸ナトリウム 0.05
(16)酢酸トコフェロール 0.1
(17)カフェイン 0.1
(18)ウイキョウエキス 0.1
(19)ハマメリスエキス 0.1
(20)ニンジンエキス 0.1
(21)酵母エキス 1
(22)エデト酸三ナトリウム 0.05
(23)ジモルホリノピリダジノン 0.01
(24)トリメトキシ桂皮酸メチルビス(トリメチルシロキシ)シリルイソペンチル 0.1
(25)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(26)黄酸化鉄 適量
(27)チタン酸コバルト 適量
(28)ジメチルジステアリルアンモニウムヘクトライト 1.5
(29)ポリビニルアルコール 0.1
(30)ヒドロキシエチルセルロース 0.1
(31)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(32)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.1
(Aristoflex AVCTM;Clariant社製)
(33)香料 適量
(34)精製水 残余
Example 2 W / O cream formulation (mass%) for beam
(1) Dimethylpolysiloxane 3.0
(2) Decamethylcyclopentasiloxane 13.0
(3) Dodecamethylcyclohexasiloxane 5.0
(4) Polyoxyethylene methylpolysiloxane copolymer 1.0
(5) 3-Tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 1.0
(6) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(7) Retinol acetate 0.1
(8) paraoxybenzoic acid ester appropriate amount
(9) L-menthol appropriate amount
(10) Trimethylsiloxysilicate 2.0
(11) Ethanol 2.0
(12) Glycerin 3.0
(13) Dipropylene glycol 5.0
(14) Polyethylene glycol 6000 5.0
(15) Sodium hexametaphosphate 0.05
(16) Tocopherol acetate 0.1
(17) Caffeine 0.1
(18) Fennel extract 0.1
(19) Hamamelis extract 0.1
(20) Carrot extract 0.1
(21) Yeast extract 1
(22) edetate trisodium 0.05
(23) Dimorpholinopyridazinone 0.01
(24) methyl bis (trimethylsiloxy) silylisopentyl trimethoxycinnamate0.1
(25) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 5.0
(26) Yellow iron oxide appropriate amount
(27) Cobalt titanate appropriate amount
(28) Dimethyl distearyl ammonium hectorite 1.5
(29) Polyvinyl alcohol 0.1
(30) Hydroxyethyl cellulose 0.1
(31) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(32) (Acroyldimethyltauronium ammonium / VP) copolymer 0.1
(Aristoflex AVC TM ; manufactured by Clariant)
(33) Fragrance proper amount
(34) Purified water residue
実施例3 シワ対応O/Wクリーム
処方 (質量%)
(1)流動パラフィン 8.0
(2)ワセリン 3.0
(3)ジメチルポリシロキサン 2.0
(4)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(5)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 0.1
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(6)ステアリルアルコール 3.0
(7)ベヘニルアルコール 2.0
(8)グリセリン 5.0
(9)ジプロピレングリコール 4.0
(10)トレハロース 1.0
(11)テトラ2-エチルヘキサン酸ペンタエリスリット 4.0
(12)モノイソステアリン酸ポリオキシエチレングリセリル 2.0
(13)モノステアリン酸ポリオキシエチレングリセリン 1.0
(14)親油型モノステアリン酸グリセリン 2.0
(15)クエン酸 0.05
(16)クエン酸ナトリウム 0.05
(17)水酸化カリウム 0.015
(18)油溶性甘草エキス 0.1
(19)ブナの芽エキス 0.05
(20)パルミチン酸レチノール(100万単位) 0.25
(21)酢酸トコフェロール 0.1
(22)酵母エキス 5.0
(23)パラオキシ安息香酸エステル 適量
(24)フェノキシエタノール 適量
(25)ジブチルヒドロキシトルエン 適量
(26)エデト酸三ナトリウム 0.05
(27)4-t-ブチル-4'-メトキシジベンゾイルメタン 0.01
(28)パラメトキシ桂皮酸2-エチルヘキシル 0.1
(29)β−カロチン 0.01
(30)ポリビニルアルコール 0.5
(31)ヒドロキシエチルセルロース 0.5
(32)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(33)カルボキシビニルポリマー 0.05
(34) (アクロイルジメチルタウリンアンモニウム/VP)コポリマー 5.0
(Aristoflex AVCTM;Clariant社製)
(35)精製水 残余
(36)香料 適量
Example 3 O / W cream formulation for wrinkles (mass%)
(1) Liquid paraffin 8.0
(2) Vaseline 3.0
(3) Dimethylpolysiloxane 2.0
(4) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 1.0
(5) Dimethylpolysiloxane blend of cross-linked polymethylsiloxane 0.1
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(6) Stearyl alcohol 3.0
(7) Behenyl alcohol 2.0
(8) Glycerin 5.0
(9) Dipropylene glycol 4.0
(10) Trehalose 1.0
(11) Tetra-2-ethylhexanoic acid pentaerythritol 4.0
(12) Polyoxyethylene glyceryl monoisostearate 2.0
(13) Polystearic acid polyoxyethylene glycerol 1.0
(14) Lipophilic glyceryl monostearate 2.0
(15) Citric acid 0.05
(16) Sodium citrate 0.05
(17) Potassium hydroxide 0.015
(18) Oil soluble licorice extract 0.1
(19) Beech bud extract 0.05
(20) Retinol palmitate (million units) 0.25
(21) Tocopherol acetate 0.1
(22) Yeast extract 5.0
(23) paraoxybenzoic acid ester
(24) Appropriate amount of phenoxyethanol
(25) Appropriate amount of dibutylhydroxytoluene
(26) edetate trisodium 0.05
(27) 4-t-Butyl-4'-methoxydibenzoylmethane 0.01
(28) 2-Ethylhexyl paramethoxycinnamate 0.1
(29) β-carotene 0.01
(30) Polyvinyl alcohol 0.5
(31) Hydroxyethyl cellulose 0.5
(32) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(33) Carboxyvinyl polymer 0.05
(34) (Acroyldimethyltaurine ammonium / VP) copolymer 5.0
(Aristoflex AVC TM ; manufactured by Clariant)
(35) Purified water residue
(36) Fragrance proper amount
実施例4 保湿用O/W クリーム
処方 (質量%)
(1)流動パラフィン 10.0
(2)ジメチルポリシロキサン 2.0
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.1
(4)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物3.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(5)グリセリン 10.0
(6)1,3-ブチレングリコール 2.0
(7)エリスリトール 1.0
(8)ポリエチレングリコール1500 5.0
(9)ポリエチレングリコール6000 1.0
(10)スクワラン 15.0
(11)テトラ2-エチルヘキサン酸ペンタエリスリット 5.0
(12)水酸化カリウム 0.1
(13)ヘキサメタリン酸ナトリウム 0.05
(14)酢酸トコフェロール 0.05
(15)酵母エキス 0.1
(16)大豆発酵エキス 0.1
(17)トウニンエキス 1.0
(18)パラオキシ安息香酸エステル 適量
(19)ヒドロキシプロピルメチルセルロース 0.3
(20)ポリビニルアルコール 0.1
(21)カルボキシビニルポリマー 0.2
(22)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.5
(23)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR-2TM) 0.1
(24)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(25)精製水 残余
Example 4 O / W cream formulation for moisturizing (mass%)
(1) Liquid paraffin 10.0
(2) Dimethylpolysiloxane 2.0
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.1
(4) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 3.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) Glycerin 10.0
(6) 1,3-butylene glycol 2.0
(7) Erythritol 1.0
(8) Polyethylene glycol 1500 5.0
(9) Polyethylene glycol 6000 1.0
(10) Squalane 15.0
(11) Tetra-2-ethylhexanoic acid pentaerythrit 5.0
(12) Potassium hydroxide 0.1
(13) Sodium hexametaphosphate 0.05
(14) Tocopherol acetate 0.05
(15) Yeast extract 0.1
(16) Fermented soybean extract 0.1
(17) Tonin Extract 1.0
(18) paraoxybenzoic acid ester appropriate amount
(19) Hydroxypropyl methylcellulose 0.3
(20) Polyvinyl alcohol 0.1
(21) Carboxyvinyl polymer 0.2
(22) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.5
(23) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2 TM ) 0.1
(24) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 5.0
(25) Purified water residue
実施例5 W/Oサンスクリーン
処方 (質量%)
(1)ジメチルポリシロキサン 5.0
(2)デカメチルシクロペンタシロキサン 10.0
(3)トリメチルシロキシケイ酸 3.0
(4)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(5)ポリオキシエチレン・メチルポリシロキサン共重合体 3.0
(6)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物 5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(7)ジプロピレングリコール 3.0
(8)2−エチルヘキサン酸セチル 1.0
(9)シリコーン被覆微粒子酸化亜鉛(60nm) 10.0
(10)タルク 1.0
(11)シリコーン被覆微粒子酸化チタン(40nm) 7.0
(12)酵母エキス 1.0
(13)ヒボタウリン 0.1
(14)クララエキス 0.01
(15)アデノシン三リン酸二ナトリウム 0.5
(16)ノバラエキス 0.1
(17)パラオキシ安息香酸エステル 適量
(18)フェノキシエタノール 適量
(19)エデト酸3ナトリウム 0.2
(20)ジメチルジステアリルアンモニウムヘクトライト 1.0
(21)ポリメチルメタクリル酸共重合体球状粉末 3.0
(22無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(23)雲母チタン 0.5
(24)精製水 残余
(25)香料 適量
Example 5 W / O sunscreen formulation (mass%)
(1) Dimethylpolysiloxane 5.0
(2) Decamethylcyclopentasiloxane 10.0
(3) Trimethylsiloxysilicate 3.0
(4) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(5) Polyoxyethylene / methylpolysiloxane copolymer 3.0
(6) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(7) Dipropylene glycol 3.0
(8) Cetyl 2-ethylhexanoate 1.0
(9) Silicone coated fine particle zinc oxide (60nm) 10.0
(10) Talc 1.0
(11) Silicone coated fine particle titanium oxide (40nm) 7.0
(12) Yeast extract 1.0
(13) Hibotaurine 0.1
(14) Clara extract 0.01
(15) Adenosine triphosphate disodium 0.5
(16) Novara extract 0.1
(17) Appropriate amount of paraoxybenzoate
(18) Appropriate amount of phenoxyethanol
(19) edetate trisodium 0.2
(20) Dimethyl distearyl ammonium hectorite 1.0
(21) Polymethylmethacrylic acid copolymer spherical powder 3.0
(22 inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalytic Chemical Industry Co., Ltd.) 1.0
(23) Titanium mica 0.5
(24) Purified water residue
(25) Perfume appropriate amount
実施例6 O/Wクリーム
処方 (質量%)
(1)グリセリン 3.0
(2)デカメチルシクロペンタシロキサン 7.0
(3)ジメチルポリシロキサン 5.0
(4)モノオレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.0
(5)ポリエチレングリコール20000 0.5
(6)ポリビニルアルコール 1.0
(7)エタノール 5.0
(8)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 3.0
(9)トリメチルシロキシケイ酸 0.1
(10)ジモルホリノピリダジノン 0.1
(11)水酸化カリウム 0.12
(12)雲母チタン 0.1
(13)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物 20.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(14) (アクロイルジメチルタウリンアンモニウム/VP)コポリマー 2.0
(Aristoflex AVCTM;Clariant社製)
(15)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(16)カルボマー 0.01
(17)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR-2TM) 0.05
(18)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(19)酸化アルミニウム 0.01
(20)キサンタンガム 0.1
(21)カルボキシメチルセルロースナトリウム 0.05
(22)酵母エキス 5.0
(23)トラネキサム酸 1.0
(24)パルミチン酸レチノール(100万単位) 0.01
(25)パラオキシ安息香酸エステル 適量
(26)フェノキシエタノール 適量
(27)香料 適量
(28)イオン交換水 残余
Example 6 O / W cream
Formula (mass%)
(1) Glycerin 3.0
(2) Decamethylcyclopentasiloxane 7.0
(3) Dimethylpolysiloxane 5.0
(4) Polyoxyethylene sorbitan monooleate (20E.O.) 1.0
(5) Polyethylene glycol 20000 0.5
(6) Polyvinyl alcohol 1.0
(7) Ethanol 5.0
(8) 3-Tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 3.0
(9) Trimethylsiloxysilicate 0.1
(10) Dimorpholinopyridazinone 0.1
(11) Potassium hydroxide 0.12
(12) Titanium mica 0.1
(13) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 20.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(14) (Acroyldimethyltaurine ammonium / VP) copolymer 2.0
(Aristoflex AVC TM ; manufactured by Clariant)
(15) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(16) Carbomer 0.01
(17) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2 TM ) 0.05
(18) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 5.0
(19) Aluminum oxide 0.01
(20) Xanthan gum 0.1
(21) Sodium carboxymethylcellulose 0.05
(22) Yeast extract 5.0
(23) Tranexamic acid 1.0
(24) Retinol palmitate (1 million units) 0.01
(25) paraoxybenzoic acid ester
(26) Appropriate amount of phenoxyethanol
(27) Perfume appropriate amount
(28) Residual ion exchange water
実施例7 W/Oクリーム
処方 (質量%)
(1)ジプロピレングリコール 1.0
(2)デカメチルシクロペンタシロキサン 5.0
(3)ジメチルポリシロキサン 1.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 2.0
(5)トリ2−エチルヘキサン酸グリセリル 0.1
(6)モノステアリン酸ポリオキシエチレンソルビタン(20E.O.) 0.05
(7)ポリエチレングリコール9000 2.0
(8)ポリビニルアルコール 0.5
(9)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(10)ジモルホリノピリダジノン 0.1
(11)水酸化カリウム 0.03
(12)酸化アルミニウム 0.1
(13)酸化チタン 1.0
(14)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 40.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(15)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.1
(Aristoflex AVCTM;Clariant社製)
(16)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(17)カルボマー 0.01
(18)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR-2TM) 0.05
(19)タルク 1.0
(20)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(21)無機複合粉体(カバーリーフAR-20121MTM;触媒化成工業(株)製) 1.0
(22)無水ケイ酸 1.0
(23)ヒドロキシエチルセルロース 0.1
(24)酵母エキス 1.0
(25)大豆発酵エキス 1.0
(26)パラオキシ安息香酸エステル 適量
(27)フェノキシエタノール 適量
(28)香料 適量
(29)イオン交換水 残余
Example 7 W / O cream
Formula (mass%)
(1) Dipropylene glycol 1.0
(2) Decamethylcyclopentasiloxane 5.0
(3) Dimethylpolysiloxane 1.0
(4) Polyoxyethylene / methylpolysiloxane copolymer 2.0
(5) Glyceryl tri-2-ethylhexanoate 0.1
(6) Polystearic acid polyoxyethylene sorbitan (20E.O.) 0.05
(7) Polyethylene glycol 9000 2.0
(8) Polyvinyl alcohol 0.5
(9) 3-tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 5.0
(10) Dimorpholinopyridazinone 0.1
(11) Potassium hydroxide 0.03
(12) Aluminum oxide 0.1
(13) Titanium oxide 1.0
(14) Cross-linked polymethylsiloxane dimethylpolysiloxane blend 40.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(15) (Acroyldimethyltaurine ammonium / VP) copolymer 0.1
(Aristoflex AVC TM ; manufactured by Clariant)
(16) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(17) Carbomer 0.01
(18) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2 TM ) 0.05
(19) Talc 1.0
(20) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(21) Inorganic composite powder (Coverleaf AR-20121M TM ; manufactured by Catalytic Chemical Industry Co., Ltd.) 1.0
(22) Silicic anhydride 1.0
(23) Hydroxyethyl cellulose 0.1
(24) Yeast extract 1.0
(25) Fermented soybean extract 1.0
(26) paraoxybenzoic acid ester appropriate amount
(27) Phenoxyethanol appropriate amount
(28) Perfume appropriate amount
(29) Residual ion exchange water
実施例8 シワ・たるみ防止用O/Wクリーム
処方 (質量%)
(1)グリセリン 5.0
(2)デカメチルシクロペンタシロキサン 1.0
(3)ドデカメチルシクロヘキサシロキサン 3.0
(4)ジメチルポリシロキサン 5.0
(5)メチルフェニルポリシロキサン 1.0
(6)オクチルメトキシシンナメート 0.1
(7)テトラ2−エチルヘキサン酸ペンタエリスリット 1.0
(8)モノラウリン酸ポリオキシエチレンソルビタン(20E.O.) 0.1
(9)ポリオキシエチレン・メチルポリシロキサン共重合体 1.0
(ポリエーテル変性シリコーンオイル KF-6018TM:信越化学工業(株)製)
(10)ノバラエキス 1.0
(11)大豆発酵エキス 3.0
(12)ポリエチレングリコール6000 2.0
(13)クエン酸 0.1
(14)クエン酸ナトリウム 0.1
(15)メタリン酸ナトリウム 0.05
(16)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.1
(17)(ジメチコン/ビニルジメチコン)クロスポリマー 10.0
(KSG−16TM:信越化学工業(株)製)
(18)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 5.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(19)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.1
(Aristoflex AVCTM;Clariant社製)
(20)アクロイルジメチルタウリンアンモニウム 0.05
/Beheneth-25 メタクリレート クロスポリマー
(Aristoflex HMBTM;Clariant社製)
(21)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR-2TM) 0.05
(22)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL 600TM;SEPPIC社製) 0.5
(23)ポリアクリル酸アンモニウム(SIMULGEL ATM;SEPPIC社製) 0.5
(24)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(25)無機複合粉体(カバーリーフAR-20121MTM;触媒化成工業(株)製) 1.0
(26)(ジメチコン/ビニルジメチコン)クロスポリマー 1.0
(BY29-119TM;東レ・ダウコーニング・シリコーン社製)
(27)酵母エキス 1.0
(28)パラオキシ安息香酸エステル 適量
(29)フェノキシエタノール 適量
(30)香料 適量
(31)イオン交換水 残余
Example 8 O / W cream for preventing wrinkles and sagging
Formula (mass%)
(1) Glycerin 5.0
(2) Decamethylcyclopentasiloxane 1.0
(3) Dodecamethylcyclohexasiloxane 3.0
(4) Dimethylpolysiloxane 5.0
(5) Methylphenylpolysiloxane 1.0
(6) Octyl methoxycinnamate 0.1
(7) Tetra-2-ethylhexanoic acid pentaerythrit 1.0
(8) Polyoxyethylene sorbitan monolaurate (20E.O.) 0.1
(9) Polyoxyethylene methylpolysiloxane copolymer 1.0
(Polyether-modified silicone oil KF-6018 TM : manufactured by Shin-Etsu Chemical Co., Ltd.)
(10) Novara extract 1.0
(11) Fermented soybean extract 3.0
(12) Polyethylene glycol 6000 2.0
(13) Citric acid 0.1
(14) Sodium citrate 0.1
(15) Sodium metaphosphate 0.05
(16) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.1
(17) (Dimethicone / Vinyl Dimethicone) Crosspolymer 10.0
(KSG-16 TM: manufactured by Shin-Etsu Chemical Co., Ltd.)
(18) Crosslinked polymethylsiloxane dimethylpolysiloxane blend 5.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(19) (Acroyldimethyltauronium ammonium / VP) copolymer 0.1
(Aristoflex AVC TM ; manufactured by Clariant)
(20) Acroyldimethyltaurate ammonium 0.05
/ Beheneth-25 methacrylate cross polymer (Aristoflex HMB TM , manufactured by Clariant)
(21) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2 TM ) 0.05
(22) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL 600 TM ; manufactured by SEPPIC) 0.5
(23) Ammonium polyacrylate (SIMULGEL A TM ; manufactured by SEPPIC) 0.5
(24) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(25) Inorganic composite powder (Coverleaf AR-20121M TM ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(26) (Dimethicone / Vinyl Dimethicone) Cross Polymer 1.0
(BY29-119 ™ ; manufactured by Toray Dow Corning Silicone)
(27) Yeast extract 1.0
(28) paraoxybenzoic acid ester appropriate amount
(29) Appropriate amount of phenoxyethanol
(30) Fragrance proper amount
(31) Residual ion exchange water
実施例9 O/W乳液
処方 (質量%)
(1)ジメチルポリシロキサン 3.0
(2)デカメチルシクロペンタシロキサン 4.0
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.5
(4)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物0.5
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(5)エタノール 5.0
(6)グリセリン 6.0
(7)1,3−ブチレングリコール 5.0
(8)ポリオキシエチレンメチルグルコシド 3.0
(9)ヒマワリ油 1.0
(10)スクワラン 2.0
(11)水酸化カリウム 0.1
(12)ヘキサメタリン酸ナトリウム 0.05
(13)ヒドロキシプロピル−β−シクロデキストリン 0.1
(14)グリチルリチン酸ジカリウム 0.05
(15)ビワ葉エキス 0.1
(16)L−グルタミン酸ナトリウム 0.05
(17)ウイキョウエキス 0.1
(18)ラベンダー油 0.1
(19)ビタミンE 0.1
(20)ジオウエキス 0.1
(21)ヒボタウリン 0.01
(22)チオタウリン 0.1
(23)モルティエレラ油 0.5
(24)アルブチン 3.0
(25)アセチルヒアルロン酸ナトリウム 0.1
(26)マジョラムエキス 0.1
(27)酵母エキス 0.1
(28)ジモルホリノピリダジノン 0.1
(29)キサンタンガム 0.1
(30)カルボキシビニルポリマー 0.1
(31)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR-2TM) 0.1
(32)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 1.0
(Aristoflex AVCTM;Clariant社製)
(33)ベンガラ 適量
(34)黄酸化鉄 適量
(35)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(36)雲母チタン 0.1
(37)パラオキシ安息香酸エステル 適量
(38)精製水 残余
Example 9 O / W emulsion formulation (mass%)
(1) Dimethylpolysiloxane 3.0
(2) Decamethylcyclopentasiloxane 4.0
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.5
(4) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 0.5
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) Ethanol 5.0
(6) Glycerin 6.0
(7) 1,3-butylene glycol 5.0
(8) Polyoxyethylene methyl glucoside 3.0
(9) Sunflower oil 1.0
(10) Squalane 2.0
(11) Potassium hydroxide 0.1
(12) Sodium hexametaphosphate 0.05
(13) Hydroxypropyl-β-cyclodextrin 0.1
(14) Dipotassium glycyrrhizinate 0.05
(15) Loquat leaf extract 0.1
(16) Sodium L-glutamate 0.05
(17) Fennel extract 0.1
(18) Lavender oil 0.1
(19) Vitamin E 0.1
(20) Diau extract 0.1
(21) Hibotaurine 0.01
(22) Thiotaurine 0.1
(23) Mortierella oil 0.5
(24) Arbutin 3.0
(25) Sodium acetyl hyaluronate 0.1
(26) Marjoram extract 0.1
(27) Yeast extract 0.1
(28) Dimorpholinopyridazinone 0.1
(29) Xanthan gum 0.1
(30) Carboxyvinyl polymer 0.1
(31) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2 TM ) 0.1
(32) (Acroyldimethyltaurine ammonium / VP) copolymer 1.0
(Aristoflex AVC TM ; manufactured by Clariant)
(33) Bengala appropriate amount
(34) Yellow iron oxide
(35) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(36) Titanium mica 0.1
(37) paraoxybenzoic acid ester
(38) Purified water residue
実施例10 O/W乳液
処方 (質量%)
(1)ジメチルポリシロキサン 2.0
(2)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(4)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物 5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(5)ベヘニルアルコール 1.0
(6)バチルアルコール 0.5
(7)グリセリン 5.0
(8)1,3−ブチレングリコール 7.0
(9)エリスリトール 2.0
(10)酵母エキス 5.0
(11)シリカ被覆酸化亜鉛 0.1
(12)イチヤクソウエキス 0.1
(13)パーム硬化油 3.0
(14)スクワラン 6.0
(15)テトラ2−エチルヘキサン酸ペンタエリスリット 2.0
(16)イソステアリン酸ポリオキシエチレングリセリル 1.0
(17)モノステアリン酸ポリオキシエチレングリセリン 1.0
(18)水酸化カリウム 適量
(19)ヘキサメタリン酸ナトリウム 0.05
(20)フェノキシエタノール 適量
(21)カルボキシビニルポリマー 0.1
(22)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(23)精製水 残余
Example 10 O / W emulsion formulation (mass%)
(1) Dimethylpolysiloxane 2.0
(2) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 1.0
(4) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) Behenyl alcohol 1.0
(6) Batyl alcohol 0.5
(7) Glycerin 5.0
(8) 1,3-butylene glycol 7.0
(9) Erythritol 2.0
(10) Yeast extract 5.0
(11) Silica-coated zinc oxide 0.1
(12) Ichiyakuso Extract 0.1
(13) Hardened palm oil 3.0
(14) Squalane 6.0
(15) Tetra-2-ethylhexanoic acid pentaerythrit 2.0
(16) Polyoxyethylene glyceryl isostearate 1.0
(17) Polystearic acid polyoxyethylene glycerol 1.0
(18) Potassium hydroxide appropriate amount
(19) Sodium hexametaphosphate 0.05
(20) Appropriate amount of phenoxyethanol
(21) Carboxyvinyl polymer 0.1
(22) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(23) Purified water residue
実施例11 O/W乳液
処方 (質量%)
(1)流動パラフィン 7.0
(2)ワセリン 3.0
(3)デカメチルシクロペンタシロキサン 2.0
(4)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン0.1
(5)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 3.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(6)ベヘニルアルコール 0.5
(7)グリセリン 5.0
(8)ジプロピレングリコール 7.0
(9)ポリエチレングリコール1500 2.0
(10)ホホバ油 1.0
(11)イソステアリン酸 0.5
(12)ステアリン酸 0.5
(13)ベヘニン酸 0.5
(14)テトラ2−エチルヘキサン酸ペンタエリスリット 3.0
(15)2−エチルヘキサン酸セチル 3.0
(16)モノステアリン酸グリセリン 1.0
(17)モノステアリン酸ポリオキシエチレングリセリン 1.0
(18)水酸化カリウム 0.1
(19)ヘキサメタリン酸ナトリウム 0.05
(20)グリチルレチン酸ステアリル 0.05
(21)L−アルギニン 0.1
(22)トリメチルグリシン 0.1
(23)アスコビル-2-グルコシド 0.1
(24)キシリトール 1.0
(25)ローヤルゼリーエキス 0.1
(26)酢酸トコフェノール 0.1
(27)アセチル化ヒアルロン酸ナトリウム 0.1
(28)酵母エキス 1.0
(29)エデト酸三ナトリウム 0.05
(30)4−t−ブチル−4'−メトキシジベンゾイルメタン 0.1
(31)パラメトキシ桂皮酸2−エチルヘキシル 0.1
(32)カルボキシビニルポリマー 0.15
(33)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.5
(Aristoflex AVCTM;Clariant社製)
(34)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 0.5
(35)雲母チタン 0.1
(36)パラオキシ安息香酸エステル 適量
(37)精製水 残余
(38)香料 適量
Example 11 O / W emulsion formulation (mass%)
(1) Liquid paraffin 7.0
(2) Vaseline 3.0
(3) Decamethylcyclopentasiloxane 2.0
(4) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.1
(5) Dimethylpolysiloxane blend of crosslinked polymethylsiloxane 3.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(6) Behenyl alcohol 0.5
(7) Glycerin 5.0
(8) Dipropylene glycol 7.0
(9) Polyethylene glycol 1500 2.0
(10) Jojoba oil 1.0
(11) Isostearic acid 0.5
(12) Stearic acid 0.5
(13) Behenic acid 0.5
(14) Tetra-2-ethylhexanoic acid pentaerythritol 3.0
(15) Cetyl 2-ethylhexanoate 3.0
(16) Glycerol monostearate1.0
(17) Polystearic acid polyoxyethylene glycerol 1.0
(18) Potassium hydroxide 0.1
(19) Sodium hexametaphosphate 0.05
(20) Stearyl glycyrrhetinate 0.05
(21) L-arginine 0.1
(22) Trimethylglycine 0.1
(23) Ascovir-2-glucoside 0.1
(24) Xylitol 1.0
(25) Royal Jelly Extract 0.1
(26) Tocophenol acetate 0.1
(27) Acetylated sodium hyaluronate 0.1
(28) Yeast extract 1.0
(29) edetate trisodium 0.05
(30) 4-tert-butyl-4'-methoxydibenzoylmethane 0.1
(31) 2-ethylhexyl paramethoxycinnamate 0.1
(32) Carboxyvinyl polymer 0.15
(33) (Acroyldimethyltaurine ammonium / VP) copolymer 0.5
(Aristoflex AVC TM ; manufactured by Clariant)
(34) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 0.5
(35) Titanium mica 0.1
(36) paraoxybenzoic acid ester
(37) Purified water residue
(38) Fragrance proper amount
実施例12 W/O日中用乳液
処方 (質量%)
(1)ジメチルポリシロキサン 2.0
(2)デカメチルシクロペンタシロキサン 25.0
(3)ドデカメチルシクロヘキサシロキサン 10.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 1.5
(5)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 10.0
(6)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物5.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(7)トリメチルシロキシケイ酸 1.0
(8)1,3−ブチレングリコール 5.0
(9)スクワラン 0.5
(10)タルク 5.0
(11)グリチルリチン酸ジカリウム 0.1
(12)酢酸トコフェノール 0.1
(13)酵母エキス 0.1
(14)L−セリン 1.0
(15)アケビエキス 0.1
(16)エデト酸三ナトリウム 0.05
(17)4−t−ブチル−4'−メトキシジベンゾイルメタン 1.0
(18)パラメトキシ桂皮酸2−エチルヘキシル 5.0
(19)ジパラメトキシ桂皮酸モノ−2−エチルヘキサン酸グリセリル 1.0
(20)シリコーン被覆微粒子酸化チタン(40nm) 4.0
(21)ジメチルジステアリルアンモニウムヘクトライト 0.5
(22)球状ポリエチレン末 3.0
(23)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(24)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(25)雲母チタン 0.1
(26)フェノキシエタノール 適量
(27)精製水 残余
(28)香料 適量
Example 12 W / O daytime emulsion formulation (mass%)
(1) Dimethylpolysiloxane 2.0
(2) Decamethylcyclopentasiloxane 25.0
(3) Dodecamethylcyclohexasiloxane 10.0
(4) Polyoxyethylene / methylpolysiloxane copolymer 1.5
(5) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 10.0
(6) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(7) Trimethylsiloxysilicate 1.0
(8) 1,3-butylene glycol 5.0
(9) Squalane 0.5
(10) Talc 5.0
(11) Dipotassium glycyrrhizinate 0.1
(12) Tocophenol acetate 0.1
(13) Yeast extract 0.1
(14) L-serine 1.0
(15) Akebi extract 0.1
(16) edetate trisodium 0.05
(17) 4-t-butyl-4'-methoxydibenzoylmethane 1.0
(18) 2-Ethylhexyl paramethoxycinnamate5.0
(19) Diparamethoxycinnamate mono-2-ethylhexanoate glyceryl 1.0
(20) Silicone coated fine particle titanium oxide (40nm) 4.0
(21) Dimethyl distearyl ammonium hectorite 0.5
(22) Spherical polyethylene powder 3.0
(23) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(24) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(25) Titanium mica 0.1
(26) Appropriate amount of phenoxyethanol
(27) Purified water residue
(28) Perfume appropriate amount
実施例13 化粧水
処方 (質量%)
(1)エチルアルコール 5.0
(2)グリセリン 1.0
(3)1,3−ブチレングリコール 5.0
(4)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(5)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物1.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(6)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン1.0
(7)ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル0.2
(8)ヘキサメタリン酸ナトリウム 0.03
(9)トリメチルグリシン 1.0
(10)ポリアスパラギン酸ナトリウム 0.1
(11)α-トコフェロール 2-L-アスコルビン酸リン酸ジエステルカリウム 0.1
(12)チオタウリン 0.1
(13)緑茶エキス 0.1
(14)西洋ハッカエキス 0.1
(15)α―グルコシルヘスペリジン 0.01
(16)アスコルビン酸リン酸エステルマグネシウム 0.01
(17)4-メトキシサリチル酸カリウム 1.0
(18)イリス根エキス 0.1
(19)酵母エキス 0.01
(20)HEDTA3ナトリウム 0.1
(21)カルボキシビニルポリマー 0.05
(22)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.05
(23)水酸化カリウム 0.02
(24)フェノキシエタノール 適量
(25)精製水 残余
(26)香料 適量
Example 13 skin lotion formula (mass%)
(1) Ethyl alcohol 5.0
(2) Glycerin 1.0
(3) 1,3-butylene glycol 5.0
(4) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(5) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 1.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(6) 3-tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 1.0
(7) Polyoxyethylene polyoxypropylene decyl tetradecyl ether 0.2
(8) Sodium hexametaphosphate 0.03
(9) Trimethylglycine 1.0
(10) Sodium polyaspartate 0.1
(11) α-tocopherol 2-L-ascorbic acid phosphate diester potassium 0.1
(12) Thiotaurine 0.1
(13) Green tea extract 0.1
(14) Western mint extract 0.1
(15) α-Glucosyl hesperidin 0.01
(16) Magnesium ascorbate phosphate 0.01
(17) Potassium 4-methoxysalicylate1.0
(18) Iris root extract 0.1
(19) Yeast extract 0.01
(20) HEDTA 3 sodium 0.1
(21) Carboxyvinyl polymer 0.05
(22) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.05
(23) Potassium hydroxide 0.02
(24) Appropriate amount of phenoxyethanol
(25) Purified water residue
(26) Perfume appropriate amount
実施例14 化粧水
処方 (質量%)
(1)エタノール 10.0
(2)グリセリン 2.0
(3)ジプロピレングリコール 1.0
(4)イソステアリン酸 0.1
(5)ポリ(オキシエチレン・オキシプロピレン)・メチルポリシロキサン共重合体1.0
(6)ラウリルジメチルアミノ酢酸ベタイン 0.1
(7)クエン酸 0.02
(8)クエン酸ナトリウム 0.08
(9)ヘキサメタリン酸ナトリウム 0.01
(10)ヒポタウリン 0.1
(11)カモミラエキス 0.1
(12)オウゴンエキス 0.1
(13)酵母エキス 1.0
(14)ラベンダー油 0.001
(15)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 0.01
(Aristoflex AVCTM;Clariant社製)
(16)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(17)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物1.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(18)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.01
(19)フェノキシエタノール 適量
(20)活性水素水 1.0
(21)精製水 残余
Example 14 skin lotion formula (mass%)
(1) Ethanol 10.0
(2) Glycerin 2.0
(3) Dipropylene glycol 1.0
(4) Isostearic acid 0.1
(5) Poly (oxyethylene / oxypropylene) / methylpolysiloxane copolymer 1.0
(6) lauryldimethylaminoacetic acid betaine 0.1
(7) Citric acid 0.02
(8) Sodium citrate 0.08
(9) Sodium hexametaphosphate 0.01
(10) Hipotaurine 0.1
(11) Chamomile extract 0.1
(12) Ogon Extract 0.1
(13) Yeast extract 1.0
(14) Lavender oil 0.001
(15) (Acroyldimethyltaurine ammonium / VP) copolymer 0.01
(Aristoflex AVC TM ; manufactured by Clariant)
(16) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(17) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 1.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(18) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.01
(19) Phenoxyethanol appropriate amount
(20) Active hydrogen water 1.0
(21) Purified water residue
実施例15 パック
処方 (質量%)
(1)エタノール 10.0
(2)1,3−ブチレングリコール 6.0
(3)ポリエチレングリコール4000 2.0
(4)オリーブ油 1.0
(5)マカデミアナッツ油 1.0
(6)ヒドロキシステアリン酸フィトステリル 0.05
(7)乳酸 0.05
(8)乳酸ナトリウム 0.1
(9)L−アスコルビン酸硫酸エステル2ナトリウム 0.1
(10)α-トコフェロール 2-L-アスコルビン酸リン酸ジエステルカリウム 0.1
(11)酢酸トコフェノール 0.1
(12)魚コラーゲン 0.1
(13)糖蜜エキス 1.0
(14)コンドロイチン硫酸ナトリウム 0.1
(15)酵母エキス 3.0
(16)カルボキシメチルセルロースナトリウム 0.2
(17)ポリビニルアルコール 12.0
(18)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー 2.0
(Aristoflex AVCTM;Clariant社製)
(19)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.1
(20)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 3.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(21)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(22)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(23)パラオキシ安息香酸エステル 適量
(24)精製水 残余
(25)香料 適量
Example 15 Pack formulation (mass%)
(1) Ethanol 10.0
(2) 1,3-butylene glycol 6.0
(3) Polyethylene glycol 4000 2.0
(4) Olive oil 1.0
(5) Macadamia nut oil 1.0
(6) Phytosteryl hydroxystearate 0.05
(7) Lactic acid 0.05
(8) Sodium lactate 0.1
(9) L-ascorbic acid sulfate disodium 0.1
(10) α-Tocopherol 2-L-ascorbic acid potassium phosphate diester 0.1
(11) Tocophenol acetate 0.1
(12) Fish collagen 0.1
(13) Molasses extract 1.0
(14) Sodium chondroitin sulfate 0.1
(15) Yeast extract 3.0
(16) Carboxymethylcellulose sodium 0.2
(17) Polyvinyl alcohol 12.0
(18) (Acroyldimethyltaurine ammonium / VP) copolymer 2.0
(Aristoflex AVC TM ; manufactured by Clariant)
(19) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.1
(20) Dimethylpolysiloxane blend of cross-linked polymethylsiloxane 3.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(21) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalytic Chemical Industry Co., Ltd.)
(22) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 1.0
(23) paraoxybenzoic acid ester
(24) Purified water residue
(25) Perfume appropriate amount
実施例16 粉末固形ファンデーション
処方 (質量%)
(1)ジメチルポリシロキサン 5.0
(2)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物5.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.5
(4)イソステアリン酸酸 0.5
(5)リンゴ酸ジイソステアリル 3.0
(6)トリ2−エチルヘキサンサングリセリル 1.0
(7)セスキイソステアリン酸ソルビタン 1.0
(8)球状PMMA被覆雲母 6.0
(9)プリズムトーンパウダーYR 1.0
(10)微粒子酸化亜鉛 0.5
(11)微粒子酸化チタン 2.0
(12)合成金雲母 2.0
(13)金属石鹸処理タルク 8.0
(14)球状無水ケイ酸 5.0
(15)酢酸トコフェノール 0.1
(16)δ-トコフェロール 0.1
(17)イザヨイバラエキス 0.1
(18)酵母エキス 0.1
(19)パラオキシ安息香酸エステル 適量
(20)トリメトキシ桂皮酸メチルビス(トリメチルシロキシ)シリルイソペンチル1.0
(21)パラメトキシ桂皮酸2−エチルへキシル 3.0
(22)球状ポリアクリル酸アルキル粉末 6.0
(23)メチルハイドロジェンポリシロキサン被覆タルク 残余
(24)メチルハイドロジェンポリシロキサン被覆セリサイト 5.0
(25)メチルハイドロジェンポリシロキサン被覆酸化チタン 15.0
(26)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 10.0
(27)雲母チタン 1.0
(28)メチルハイドロジェンポリシロキサン被覆顔料(色剤) 5.0
Example 16 Powdered solid foundation formulation (mass%)
(1) Dimethylpolysiloxane 5.0
(2) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.5
(4) Isostearic acid 0.5
(5) Diisostearyl malate 3.0
(6) Tri-2-ethylhexane sanglyceryl 1.0
(7) Sorbitan sesquiisostearate 1.0
(8) Spherical PMMA-coated mica 6.0
(9) Prism tone powder YR 1.0
(10) Fine zinc oxide 0.5
(11) Fine particle titanium oxide 2.0
(12) Synthetic phlogopite 2.0
(13) Metal soap treated talc 8.0
(14) Spherical silica 5.0
(15) Tocophenol acetate 0.1
(16) δ-Tocopherol 0.1
(17) Isaiyo Rose Extract 0.1
(18) Yeast extract 0.1
(19) paraoxybenzoic acid ester
(20) methyl bis (trimethylsiloxy) silylisopentyl trimethoxycinnamate 1.0
(21) 2-ethylhexyl paramethoxycinnamate 3.0
(22) Spherical polyalkyl acrylate powder 6.0
(23) Methyl hydrogen polysiloxane coated talc Residue
(24) Methylhydrogenpolysiloxane-coated sericite 5.0
(25) Methyl hydrogen polysiloxane coated titanium oxide 15.0
(26) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 10.0
(27) Titanium mica 1.0
(28) Methyl hydrogen polysiloxane coated pigment (colorant) 5.0
実施例17 粉末固形ファンデーション
処方 (質量%)
(1)セレシン 0.5
(2)ジメチルポリシロキサン 2.0
(3)メチルフェニルポリシロキサン 1.0
(4)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(5)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(6)スクワラン 7.0
(7)スクワラン(植物性) 1.0
(8)セスキイソステアリン酸ソルビタン 1.0
(9)グリセロール変性シリコーン樹脂被覆焼成セリサイト 16.0
(10)グリセロール変性シリコーン樹脂被覆セリサイト 7.0
(11)黄酸化鉄被覆雲母チタン 0.1
(12)微粒子酸化チタン 5.0
(13)タルク 10.0
(14)酸化チタン被覆セリサイト 0.1
(15)窒化ホウ素 2.5
(16)ベンガラ被覆雲母チタン 0.1
(17)フィトステロール 0.1
(18)ジパルミチン酸アスコルビル 0.1
(19)酢酸DL−α−トコフェロール 0.1
(20)D−δ−トコフェロール 0.1
(21)酵母エキス 0.1
(22)パラオキシ安息香酸エステル 適量
(23)パラメトキシ桂皮酸2−エチルへキシル 1.0
(24)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 10.0
(25)球状ポリアクリル酸アルキル粉末 8.0
(26)メチルハイドロジェンポリシロキサン被覆雲母 残余
(27)メチルハイドロジェンポリシロキサン被覆酸化鉄酸化チタン焼結物 5.0
(28)メチルハイドロジェンポリシロキサン被覆セリサイト 5.0
(29)メチルハイドロジェンポリシロキサン被覆酸化チタン 4.0
(30)メチルハイドロジェンポリシロキサン被覆薄片状酸化チタン 5.0
(31)メチルハイドロジェンポリシロキサン被覆顔料(色剤) 5.0
(32)香料 適量
Example 17 Powdered solid foundation formulation (mass%)
(1) Ceresin 0.5
(2) Dimethylpolysiloxane 2.0
(3) Methylphenylpolysiloxane 1.0
(4) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(5) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(6) Squalane 7.0
(7) Squalane (vegetable) 1.0
(8) Sorbitan sesquiisostearate 1.0
(9) Glycerol-modified silicone resin coated calcined sericite 16.0
(10) Glycerol-modified silicone resin coated sericite 7.0
(11) Yellow iron oxide coated mica titanium 0.1
(12) Fine particle titanium oxide 5.0
(13) Talc 10.0
(14) Titanium oxide coated sericite 0.1
(15) Boron nitride 2.5
(16) Bengala-coated mica titanium 0.1
(17) Phytosterol 0.1
(18) Ascorbyl dipalmitate 0.1
(19) DL-α-tocopherol acetate 0.1
(20) D-δ-tocopherol 0.1
(21) Yeast extract 0.1
(22) paraoxybenzoic acid ester appropriate amount
(23) 2-ethylhexyl paramethoxycinnamate 1.0
(24) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 10.0
(25) Spherical polyalkyl acrylate powder 8.0
(26) Methyl hydrogen polysiloxane-coated mica residue
(27) Methyl hydrogen polysiloxane coated iron oxide titanium oxide sintered product 5.0
(28) Methylhydrogenpolysiloxane-coated sericite 5.0
(29) Methyl hydrogen polysiloxane coated titanium oxide 4.0
(30) Methyl hydrogen polysiloxane coated flaky titanium oxide 5.0
(31) Methyl hydrogen polysiloxane coated pigment (colorant) 5.0
(32) Fragrance proper amount
実施例18 粉末固形ファンデーション
処方 (質量%)
(1)α−オレフィンオリゴマー 3.0
(2)ワセリン 3.0
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(4)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物3.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(5)マカデミアナッツ油 0.1
(6)セスキイソステアリン酸ソルビタン 1.0
(7)アルキル変性シリコーン樹脂被覆黄酸化鉄 2.0
(8)アルキル変性シリコーン樹脂被覆ベンガラ 1.0
(9)アルキル変性シリコーン樹脂被覆黒酸化鉄 0.5
(10)黄酸化鉄被覆雲母チタン 5.0
(11)合成金雲母 5.0
(12)酸化チタン 1.0
(13)酸化亜鉛 1.0
(14)低温焼成酸化亜鉛 4.0
(15)焼成セリサイト 10.0
(16)金雲母 1.0
(17)酸化アルミニウム 1.0
(18)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 15.0
(19)タルク 残余
(20)合成金雲母 5.0
(21)架橋型シリコーン末 10.0
(トレフィルE-506TM:東レ・ダウ・コーニング・シリコーン社製)
(22)酢酸DL−α−トコフェロール 0.1
(23)D−δ−トコフェロール 0.1
(24)酵母エキス 5.0
(25)パラオキシ安息香酸エステル 適量
(26)パラメトキシ桂皮酸2−エチルへキシル 1.0
(27)アルギン酸カルシウム粉末 1.0
(28)香料 適量
Example 18 Powdered solid foundation formulation (mass%)
(1) α-olefin oligomer 3.0
(2) Vaseline 3.0
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(4) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 3.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) Macadamia nut oil 0.1
(6) Sorbitan sesquiisostearate 1.0
(7) Alkyl-modified silicone resin coated yellow iron oxide 2.0
(8) Alkyl modified silicone resin coated Bengala 1.0
(9) Black iron oxide coated with alkyl-modified silicone resin 0.5
(10) Yellow iron oxide coated mica titanium 5.0
(11) Synthetic phlogopite 5.0
(12) Titanium oxide 1.0
(13) Zinc oxide 1.0
(14) Low-temperature calcined zinc oxide 4.0
(15) Firing sericite 10.0
(16) Golden Mica 1.0
(17) Aluminum oxide 1.0
(18) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 15.0
(19) Talc residue
(20) Synthetic phlogopite 5.0
(21) Cross-linked silicone powder 10.0
(Trefill E-506 TM : Toray Dow Corning Silicone)
(22) DL-α-tocopherol acetate 0.1
(23) D-δ-tocopherol 0.1
(24) Yeast extract 5.0
(25) paraoxybenzoic acid ester
(26) 2-Ethylhexyl paramethoxycinnamate 1.0
(27) Calcium alginate powder 1.0
(28) Perfume appropriate amount
実施例19 固形ファンデーション
処方 (質量%)
(1)α−オレフィンオリゴマー 10.0
(2)マイクロクリスタリンワックス 0.5
(3)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 3.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(4)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 1.0
(5)セレシン 5.0
(6)ジメチルポリシロキサン 15.0
(7)メチルフェニルポリシロキサン 10.0
(8)マカデミアナッツ油 0.1
(9)カルナウバロウ 0.1
(10)トリ2−エチルヘキサン酸グリセリル 7.0
(11)2−エチルヘキサン酸セチル 10.0
(12)セスキイソステアリン酸ソルビタン 1.5
(13)マイカ 0.5
(14)ステアリン酸アルミニウム 1.0
(15)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 3.0
(16)架橋型シリコーン末 8.0
(トレフィルE-506TM:東レ・ダウ・コーニング・シリコーン社製)
(17)N−ラウロイル−L−リジン 0.1
(18)D−δ−トコフェロール 適量
(19)酵母エキス 0.1
(20)ベンガラ 適量
(21)黄酸化鉄 適量
(22)アルギン酸カルシウム粉末 1.0
(23)ナイロン末 残余
(24)球状無水ケイ酸 1.0
(25)酸化チタン 1.0
Example 19 Solid foundation formulation (mass%)
(1) α-olefin oligomer 10.0
(2) Microcrystalline wax 0.5
(3) Crosslinked polymethylsiloxane dimethylpolysiloxane blend 3.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(4) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 1.0
(5) Ceresin 5.0
(6) Dimethylpolysiloxane 15.0
(7) Methylphenylpolysiloxane 10.0
(8) Macadamia nut oil 0.1
(9) Carnauba 0.1
(10) Glyceryl tri-2-ethylhexanoate 7.0
(11) Cetyl 2-ethylhexanoate 10.0
(12) Sorbitan sesquiisostearate 1.5
(13) Mica 0.5
(14) Aluminum stearate 1.0
(15) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 3.0
(16) Cross-linked silicone powder 8.0
(Trefill E-506 TM : Toray Dow Corning Silicone)
(17) N-lauroyl-L-lysine 0.1
(18) Appropriate amount of D-δ-tocopherol
(19) Yeast extract 0.1
(20) Bengala appropriate amount
(21) Yellow iron oxide appropriate amount
(22) Calcium alginate powder 1.0
(23) Nylon powder residual
(24) Spherical Silicic Acid 1.0
(25) Titanium oxide 1.0
実施例20 乳化ファンデーション
処方 (質量%)
(1)マイクロクリスタリンワックス 1.0
(2)ジメチルポリシロキサン 15.0
(3)デカメチルシクロペンタシロキサン 2.0
(4)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物3.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(5)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.5
(6)1,3−ブチレングリコール 6.0
(7)キャンデリラロウ 3.0
(8)イソステアリン酸 1.0
(9)エチレングリコール脂肪酸エステル 0.1
(10)ラノリン脂肪酸オクチルドデシル 0.5
(11)2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン
4.0
(12)酸化チタン 7.5
(13)硫酸バリウム 5.0
(14)酸化チタン 7.0
(15)タルク 3.0
(16)無水ケイ酸 4.0
(17)架橋型シリコーン末 0.1
(トレフィルE-506TM:東レ・ダウ・コーニング・シリコーン社製)
(18)メタリン酸ナトリウム 0.1
(19)ヒドロキシプロピル−β−シクロデキストリン 0.1
(20)酢酸DL−α−トコフェロール 0.1
(21)ハマメリス抽出液 0.1
(22)シャクヤクエキス 0.1
(23)コンドロイチン硫酸ナトリウム 0.1
(24)ヒアルロン酸ナトリウム 0.1
(25)酵母エキス 0.1
(26)アセンヤクエキス 0.1
(27)パラオキシ安息香酸エステル 適量
(28)ベンガラ 適量
(29)黄酸化鉄 適量
(30)黒酸化鉄 適量
(31)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(32)キサンタンガム 0.1
(33)カルボキシメチルセルロースナトリウム 0.1
(34)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 0.5
(35)メリロートエキス 2.0
(36)精製水 残余
Example 20 Emulsion foundation formulation (mass%)
(1) Microcrystalline wax 1.0
(2) Dimethylpolysiloxane 15.0
(3) Decamethylcyclopentasiloxane 2.0
(4) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 3.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) 3-tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 0.5
(6) 1,3-butylene glycol 6.0
(7) Candelilla Row 3.0
(8) Isostearic acid 1.0
(9) Ethylene glycol fatty acid ester 0.1
(10) Lanolin fatty acid octyldodecyl 0.5
(11) 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine
4.0
(12) Titanium oxide 7.5
(13) Barium sulfate 5.0
(14) Titanium oxide 7.0
(15) Talc 3.0
(16) Silicic anhydride 4.0
(17) Cross-linked silicone powder 0.1
(Trefill E-506 TM : Toray Dow Corning Silicone)
(18) Sodium metaphosphate 0.1
(19) Hydroxypropyl-β-cyclodextrin 0.1
(20) DL-α-tocopherol acetate 0.1
(21) Hamamelis extract 0.1
(22) Peonies extract 0.1
(23) Sodium chondroitin sulfate 0.1
(24) Sodium hyaluronate 0.1
(25) Yeast extract 0.1
(26) Asenya extract 0.1
(27) paraoxybenzoic acid ester appropriate amount
(28) Bengala appropriate amount
(29) Yellow iron oxide appropriate amount
(30) Black iron oxide
(31) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(32) Xanthan gum 0.1
(33) Sodium carboxymethyl cellulose 0.1
(34) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 0.5
(35) Merirot Extract 2.0
(36) Purified water residue
実施例21 W/Oファンデーション
処方 (質量%)
(1)ジメチルポリシロキサン 3.0
(2)デカメチルシクロペンタシロキサン 10.0
(3)ポリオキシエチレン・メチルポリシロキサン共重合体 3.0
(4)ドデカメチルシクロヘキサシロキサン 5.0
(5)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.1
(6)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(7)グリセリン 4.0
(8)1,3-ブチレングリコール 5.0
(9)パルミチン酸 0.5
(10)塩化ジステアリルジメチルアンモニウム 0.2
(11)金属石鹸処理タルク 2.0
(12)架橋型シリコーン末 0.1
(トレフィルE-506TM:東レ・ダウ・コーニング・シリコーン社製)
(13)ベンガラ被覆雲母チタン 0.5
(14)N−ラウロイル−L−リジン 2.0
(15)L−グルタミン酸ナトリウム 2.0
(16)酢酸トコフェロール 0.1
(17)δ−トコフェロール 0.1
(18)パラオキシ安息香酸エステル 適量
(19)フェノキシエタノール 0.2
(20)球状ナイロン末 1.0
(21)球状ポリアクリル酸アルキル粉末 3.0
(22)メリロートエキス 2.0
(23)ヒオウギエキス 1.0
(24)酵母エキス 5.0
(25)精製水 残余
(26)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 2.0
(27)デキストリン脂肪酸処理タルク 3.0
(28)デキストリン脂肪酸処理二酸化チタン 15.0
(29)デキストリン脂肪酸処理黄酸化鉄 3.0
(30)デキストリン脂肪酸処理黒酸化鉄 0.5
Example 21 W / O foundation prescription (mass%)
(1) Dimethylpolysiloxane 3.0
(2) Decamethylcyclopentasiloxane 10.0
(3) Polyoxyethylene / methylpolysiloxane copolymer 3.0
(4) Dodecamethylcyclohexasiloxane 5.0
(5) 3-tris (trimethylsiloxy) silylpropylcarbamic acid pullulan 0.1
(6) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(7) Glycerin 4.0
(8) 1,3-butylene glycol 5.0
(9) Palmitic acid 0.5
(10) Distearyldimethylammonium chloride 0.2
(11) Metal soap treated talc 2.0
(12) Cross-linked silicone powder 0.1
(Trefill E-506 TM : Toray Dow Corning Silicone)
(13) Bengala coated mica titanium 0.5
(14) N-lauroyl-L-lysine 2.0
(15) Sodium L-glutamate 2.0
(16) Tocopherol acetate 0.1
(17) δ-Tocopherol 0.1
(18) paraoxybenzoic acid ester appropriate amount
(19) Phenoxyethanol 0.2
(20) Spherical nylon powder 1.0
(21) Spherical polyalkyl acrylate powder 3.0
(22) Merirot Extract 2.0
(23) Cypress extract 1.0
(24) Yeast extract 5.0
(25) Purified water residue
(26) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 2.0
(27) Dextrin fatty acid treatment talc 3.0
(28) Dextrin fatty acid-treated titanium dioxide 15.0
(29) Dextrin fatty acid-treated yellow iron oxide 3.0
(30) Dextrin fatty acid treated black iron oxide 0.5
実施例22 O/Wファンデーション
処方 (質量%)
(1)ジメチルポリシロキサン 8.0
(2)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物20.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(4)ベヘニルアルコール 0.5
(5)バチルアルコール 0.5
(6)1,3−ブチレングリコール 5.0
(7)マカデミアナッツ油 0.1
(8)イソステアリン酸 1.5
(9)ステアリン酸 1.0
(10)ベヘニン酸 0.5
(11)2-エチルヘキサン酸セチル 5.0
(12)モノステアリン酸ポリオキシエチレングリセリン 1.0
(13)自己乳化型モノステアリン酸グリセリン 1.0
(14)黄酸化鉄被覆雲母チタン 2.0
(15)酸化チタン 4.0
(16)タルク 0.5
(17)カオリン 3.0
(18)合成金雲母 0.1
(19)架橋型シリコーン末 0.1
(20)無水ケイ酸 5.0
(21)水酸化カリウム 0.2
(22)トリエタノールアミン 0.8
(23)酢酸DL−α−トコフェロール 0.1
(24)ヒアルロン酸ナトリウム 0.1
(25)酵母エキス 0.1
(26)イブキジャコウエキス 0.1
(27)パラオキシ安息香酸エステル 適量
(28)パラメトキシ桂皮酸2−エチルへキシル 1.0
(29)ベンガラ 適量
(30)黄酸化鉄 適量
(31)黒酸化鉄 適量
(32)キサンタンガム 0.1
(33)アクリル酸ナトリウム/2-アクリルアミド-2-メチルプロパンスルホン酸共重合体
(SIMULGEL EGTM;SEPPIC社製) 1.0
(34)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(35)ベントナイト 1.0
(36)カルボキシメチルセルロースナトリウム 0.1
(37)精製水 残余
(38)香料 適量
Example 22 O / W foundation formulation (mass%)
(1) Dimethylpolysiloxane 8.0
(2) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 20.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(4) Behenyl alcohol 0.5
(5) Batyl alcohol 0.5
(6) 1,3-butylene glycol 5.0
(7) Macadamia nut oil 0.1
(8) Isostearic acid 1.5
(9) Stearic acid 1.0
(10) Behenic acid 0.5
(11) Cetyl 2-ethylhexanoate 5.0
(12) Poly stearate polyoxyethylene glycerin 1.0
(13) Self-emulsifying glyceryl monostearate1.0
(14) Yellow iron oxide coated mica titanium 2.0
(15) Titanium oxide 4.0
(16) Talc 0.5
(17) Kaolin 3.0
(18) Synthetic phlogopite 0.1
(19) Cross-linked silicone powder 0.1
(20) Silicic anhydride 5.0
(21) Potassium hydroxide 0.2
(22) Triethanolamine 0.8
(23) DL-α-tocopherol acetate 0.1
(24) Sodium hyaluronate 0.1
(25) Yeast extract 0.1
(26) Ibuki extract 0.1
(27) paraoxybenzoic acid ester appropriate amount
(28) 2-Methylhexyl paramethoxycinnamate 1.0
(29) Bengala appropriate amount
(30) Yellow iron oxide
(31) Appropriate amount of black iron oxide
(32) Xanthan gum 0.1
(33) Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer
(SIMULGEL EG TM ; manufactured by SEPPIC) 1.0
(34) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 5.0
(35) Bentonite 1.0
(36) Carboxymethylcellulose sodium 0.1
(37) Purified water residue
(38) Fragrance proper amount
実施例23 ファンデーション
処方 (質量%)
(1)ドデカメチルシクロヘキサシロキサン 15.0
(2)デカメチルシクロペンタシロキサン 残余
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン5.0
(4)架橋型ポリメチルシロキサンのジメチルポリシロキサン配合物 30.0
(Dow Corning 9041 Silicone Elastomer BlendTM:Dow Corning社製)
(5)エタノール 10.0
(6)イソステアリン酸 0.5
(7)ミリスチン酸処理酸化亜鉛 0.5
(8)パルミチン酸デキストリン被覆酸化チタン 10.0
(9)パルミチン酸デキストリン被覆タルク 7.0
(10)シリコーン表面処理酸化チタン(30nm) 5.0
(11)架橋型シリコーン末 1.0
(12)球状無水ケイ酸 2.0
(13)リン酸L−アスコルビルマグネシウム 0.2
(14)酢酸DL−α−トコフェロール 0.1
(15)D−δ−トコフェロール 0.1
(16)グルタチオン 0.1
(17)クララエキス 0.1
(18)サイコエキス 1.0
(19)酵母エキス 2.0
(20)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 1.0
(21)パラメトキシ桂皮酸2−エチルへキシル 5.0
(22)パルミチン酸デキストリン被覆ベンガラ 適量
(23)パルミチン酸デキストリン被覆黄酸化鉄 適量
(24)パルミチン酸デキストリン被覆黒酸化鉄 適量
(25)香料 適量
Example 23 Foundation formulation (mass%)
(1) Dodecamethylcyclohexasiloxane 15.0
(2) Decamethylcyclopentasiloxane Residue
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(4) Crosslinked polymethylsiloxane dimethylpolysiloxane blend 30.0
(Dow Corning 9041 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(5) Ethanol 10.0
(6) Isostearic acid 0.5
(7) Myristic acid-treated zinc oxide 0.5
(8) Dextrin palmitate coated titanium oxide 10.0
(9) Dalmic palmitate coated talc 7.0
(10) Silicone surface-treated titanium oxide (30 nm) 5.0
(11) Cross-linked silicone powder 1.0
(12) Spherical silica 2.0
(13) L-ascorbyl magnesium phosphate 0.2
(14) DL-α-tocopherol acetate 0.1
(15) D-δ-tocopherol 0.1
(16) Glutathione 0.1
(17) Clara extract 0.1
(18) Psycho extract 1.0
(19) Yeast extract 2.0
(20) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 1.0
(21) 2-Methylhexyl paramethoxycinnamate5.0
(22) Bengala coated with dextrin palmitate
(23) Appropriate amount of dextrin palmitate-coated yellow iron oxide
(24) Appropriate amount of black iron oxide coated with dextrin palmitate
(25) Perfume appropriate amount
実施例24 化粧下地
処方 (質量%)
(1)ジメチルポリシロキサン 5.0
(2)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 0.1
(3)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物30.0
(Dow Corning 9045 Silicone Elastomer BlendTM:Dow Corning社製)
(4)デカメチルシクロペンタシロキサン 残余
(5)エチルアルコール 8.0
(6)紺青被覆雲母チタン 0.5
(7)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 5.0
(8)メチルシロキサン網状重合体 5.0
(9)架橋型シリコーン末 5.0
(トレフィルE-506TM:東レ・ダウ・コーニング・シリコーン社製)
(10)クエン酸 0.02
(11)クエン酸ナトリウム 0.08
(12)酢酸トコフェロール 0.1
(13)δ−トコフェロール 0.1
(14)メリロートエキス 3.0
(15)ウコンエキス 0.01
(16)酵母エキス 0.1
(17)精製水 1.0
(18)ポリ(オキシエチレン・オキシプロピレン)・メチルポリシロキ酸共重合体 5.0
Example 24 Makeup Base Formula (mass%)
(1) Dimethylpolysiloxane 5.0
(2) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 0.1
(3) Decamethylcyclopentasiloxane blend of crosslinked polymethylsiloxane 30.0
(Dow Corning 9045 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(4) Decamethylcyclopentasiloxane Residue
(5) Ethyl alcohol 8.0
(6) Bitumen coated mica titanium 0.5
(7) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 5.0
(8) Methylsiloxane network polymer 5.0
(9) Cross-linked silicone powder 5.0
(Trefill E-506 TM : Toray Dow Corning Silicone)
(10) Citric acid 0.02
(11) Sodium citrate 0.08
(12) Tocopherol acetate 0.1
(13) δ-tocopherol 0.1
(14) Merirot Extract 3.0
(15) Turmeric extract 0.01
(16) Yeast extract 0.1
(17) Purified water 1.0
(18) Poly (oxyethylene / oxypropylene) / methylpolysiloxy acid copolymer 5.0
実施例25 化粧下地
処方 (質量%)
(1)ジメチルポリシロキサン 5.0
(2)架橋型ポリメチルシロキサンのデカメチルシクロペンタシロキサン配合物5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(3)3-トリス(トリメチルシロキシ)シリルプロピルカルバミド酸プルラン 5.0
(4)デカメチルシクロペンタシロキサン 25.0
(5)ポリオキシエチレン・メチルポリシロキサン共重合体 3.0
(6)グリセリン 1.0
(7)1,3−ブチレングリコール 5.0
(8)キシリット 0.5
(9)イソステアリン酸 0.5
(10)無機複合粉体(カバーリーフAR-80TM;触媒化成工業(株)製) 10.0
(11)アルキル変性シリコーン樹脂被覆無水ケイ酸 2.0
(12)タルク 0.5
(13)ステアリン酸アルミニウム 1.0
(14)ベンガラ被覆雲母チタン 0.1
(15)ヘキサメタリン酸ナトリウム 0.05
(16)グリチルリチン酸ジカリウム 0.1
(17)L−セリン 0.1
(18)オトギリソウエキス 0.1
(19)酢酸DL−α−トコフェロール 0.2
(20)チオタウリン 0.1
(21)トゲナシエキス 0.1
(22)シャクヤクエキス 0.1
(23)リゾレシチン 0.01
(24)アセチル化ヒアルロン酸ナトリウム 0.1
(25)ユキノシタエキス 0.1
(26)酵母エキス 0.1
(27)パラオキシ安息香酸エステル 適量
(28)フェノキシエタノール 適量
(29)パルミチン酸デキストリン被覆黄酸化鉄 0.1
(30)ジメチルジステアリルアンモニウムヘクトライト 1.0
(31)精製水 残余
(32)トリメチルシロキシケイ酸 1.5
(33)球状無水ケイ酸 1.0
(34)球状ポリエチレン末 5.0
(35)香料 適量
Example 25 Makeup Base Formula (mass%)
(1) Dimethylpolysiloxane 5.0
(2) Decamethylcyclopentasiloxane blend of cross-linked polymethylsiloxane 5.0
(Dow Corning 9040 Silicone Elastomer Blend TM : manufactured by Dow Corning)
(3) Pullulan 3-tris (trimethylsiloxy) silylpropylcarbamate 5.0
(4) Decamethylcyclopentasiloxane 25.0
(5) Polyoxyethylene / methylpolysiloxane copolymer 3.0
(6) Glycerin 1.0
(7) 1,3-butylene glycol 5.0
(8) Xylit 0.5
(9) Isostearic acid 0.5
(10) Inorganic composite powder (Coverleaf AR-80 ™ ; manufactured by Catalyst Kasei Kogyo Co., Ltd.) 10.0
(11) Silica anhydride coated with alkyl-modified silicone resin 2.0
(12) Talc 0.5
(13) Aluminum stearate 1.0
(14) Bengala-coated mica titanium 0.1
(15) Sodium hexametaphosphate 0.05
(16) Dipotassium glycyrrhizinate 0.1
(17) L-serine 0.1
(18) Hypericum extract 0.1
(19) DL-α-tocopherol acetate 0.2
(20) Thiotaurine 0.1
(21) Capsicum extract 0.1
(22) Peonies extract 0.1
(23) Lysolecithin 0.01
(24) Acetylated sodium hyaluronate 0.1
(25) Yukinoshita extract 0.1
(26) Yeast extract 0.1
(27) paraoxybenzoic acid ester appropriate amount
(28) Appropriate amount of phenoxyethanol
(29) Palmitic acid dextrin coated yellow iron oxide 0.1
(30) Dimethyl distearyl ammonium hectorite 1.0
(31) Purified water residue
(32) Trimethylsiloxysilicate 1.5
(33) Spherical silica 1.0
(34) Spherical polyethylene powder 5.0
(35) Fragrance proper amount
10 無機複合粉体
12 球状シリカ
14 酸化アルミニウム
16 酸化チタン
18 タルク
10 Inorganic
Claims (2)
(b)鱗片状基材上に、酸化チタン、酸化アルミニウム、酸化ケイ素の順に積層してなる0.1〜20質量%の無機複合粉体と、
(c)ジメチコン/ビニルジメチコンクロスポリマー、ジメチコンクロスポリマー、及びビニルジメチコン/ラウリルジメチコンクロスポリマーからなる群より選択される1種又は2種以上の架橋型ポリメチルシロキサンとを含むことを特徴とする皮膚外用剤。
(化1)
(式(I)中、Gluは多糖化合物の糖残基であり、Xはカルボニル基、アミノ基、エーテル基、カルバモイル基、及び−CH2CH(OH)−から選ばれる2価の結合基である。Yは主鎖中に酸素原子、窒素原子、硫黄原子、フェニレン基、カルボニルオキシ基又はオキシカルボニル基を有することができ、ヒドロキシ基、アルコキシ基及びアルキル基から選ばれる置換基を有することができる総炭素数2〜8のアルキレン基である。R1は炭素数1〜8の1価有機基であり、R2、R3、R4はそれぞれ同一でも異なっても良く、炭素数1〜8の1価有機基又は−OSiR5R6R7で示されるシロキシ基である。ただし、R5、R6、R7はそれぞれ同一でも異なっても良く炭素数1〜8の1価有機基である。aは0、1又は2である。) (A) 0.01 to 3.0% by mass of a siliconized polysaccharide compound having a structure represented by the following general formula (I);
(B) on a flaky substrate, titanium oxide, aluminum oxide, and inorganic composite powder of 0.1 to 20 mass% obtained by sequentially stacking a silicon oxide,
(C) dimethicone / vinyl dimethicone crosspolymer, characterized dimethicone crosspolymer, and including that the one or more crosslinked polymethylsiloxane is selected from the group consisting of vinyl dimethicone / lauryl dimethicone crosspolymer Skin external preparation.
(Chemical formula 1)
(In Formula (I), Glu is a sugar residue of the polysaccharide compound, X is a divalent linking group selected from a carbonyl group, an amino group, an ether group, a carbamoyl group, and —CH 2 CH (OH) —). Y may have an oxygen atom, a nitrogen atom, a sulfur atom, a phenylene group, a carbonyloxy group or an oxycarbonyl group in the main chain, and may have a substituent selected from a hydroxy group, an alkoxy group and an alkyl group. An alkylene group having 2 to 8 carbon atoms in total, R 1 is a monovalent organic group having 1 to 8 carbon atoms, and R 2 , R 3 , and R 4 may be the same or different; 8 or a siloxy group represented by —OSiR 5 R 6 R 7 , wherein R 5 , R 6 and R 7 may be the same or different and each is a monovalent organic group having 1 to 8 carbon atoms. A is 0, 1 or In is.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004146642A JP4570905B2 (en) | 2004-05-17 | 2004-05-17 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004146642A JP4570905B2 (en) | 2004-05-17 | 2004-05-17 | Topical skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005325088A JP2005325088A (en) | 2005-11-24 |
JP4570905B2 true JP4570905B2 (en) | 2010-10-27 |
Family
ID=35471723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004146642A Expired - Lifetime JP4570905B2 (en) | 2004-05-17 | 2004-05-17 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4570905B2 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006282650A (en) * | 2005-03-31 | 2006-10-19 | Sunstar Inc | Skin cosmetic |
JP2007223976A (en) * | 2006-02-24 | 2007-09-06 | Shiseido Co Ltd | Makeup method for covering leukoderma part |
JP2007223961A (en) * | 2006-02-24 | 2007-09-06 | Shiseido Co Ltd | Skin care composition for melanin-insufficient part |
JP4849937B2 (en) * | 2006-04-05 | 2012-01-11 | 花王株式会社 | Topical skin preparation |
JP4842686B2 (en) * | 2006-04-05 | 2011-12-21 | 花王株式会社 | Topical skin preparation |
WO2007097128A2 (en) * | 2006-05-23 | 2007-08-30 | Shiseido Company, Ltd. | Powder cosmetic composition cotaining humectant in high concentration |
JP5080075B2 (en) * | 2006-12-13 | 2012-11-21 | 株式会社 資生堂 | Method for improving skin sagging and kit for improving skin sagging |
JP4931631B2 (en) * | 2007-02-20 | 2012-05-16 | 株式会社トキワ | Water-in-oil emulsified makeup cosmetic |
JP5165304B2 (en) * | 2007-08-02 | 2013-03-21 | 花王株式会社 | Cosmetics |
JP5394635B2 (en) * | 2007-12-07 | 2014-01-22 | 正一 中村 | Cleaning additive and method for producing the same |
TWI411448B (en) * | 2007-12-27 | 2013-10-11 | Avon Prod Inc | Optical blurring pigment composition suitable for use in cosmetics |
JP2009242326A (en) * | 2008-03-31 | 2009-10-22 | Shiseido Co Ltd | Skin-lightening liquid cosmetic |
JP4714241B2 (en) * | 2008-05-30 | 2011-06-29 | 株式会社 資生堂 | Oil-in-water topical skin preparation |
JP5571913B2 (en) * | 2009-07-17 | 2014-08-13 | 株式会社 資生堂 | Oil-in-water emulsified skin cosmetic |
JP2011063517A (en) * | 2009-09-15 | 2011-03-31 | Noevir Co Ltd | Gel composition |
JP5576100B2 (en) * | 2009-11-20 | 2014-08-20 | 株式会社ノエビア | Water-in-oil emulsified cosmetic |
JP5756296B2 (en) * | 2011-01-27 | 2015-07-29 | 花王株式会社 | Sheet cosmetic |
JP5802057B2 (en) * | 2011-05-31 | 2015-10-28 | 日本ゼトック株式会社 | Oil-in-water emulsified cosmetic |
TW201336520A (en) | 2012-03-05 | 2013-09-16 | Otsuka Pharma Co Ltd | Sunscreen composition |
JP5795281B2 (en) * | 2012-04-04 | 2015-10-14 | 信越化学工業株式会社 | Cosmetics |
WO2014019840A2 (en) * | 2012-08-01 | 2014-02-06 | Dow Corning Corporation | Aqueous silicone dispersions and their preparation |
JP6039369B2 (en) * | 2012-11-06 | 2016-12-07 | 花王株式会社 | Oil-in-water emulsified cosmetic |
JP6036530B2 (en) * | 2013-05-09 | 2016-11-30 | 信越化学工業株式会社 | Oil-based thickener, thickened oil-based composition and cosmetic |
JP6209438B2 (en) * | 2013-12-19 | 2017-10-04 | 花王株式会社 | Oil-in-water emulsion composition |
JP6858510B2 (en) * | 2016-08-31 | 2021-04-14 | 花王株式会社 | Water-in-oil emulsified cosmetic |
JP7222503B2 (en) * | 2016-10-27 | 2023-02-15 | 株式会社東洋新薬 | Skin topical agent |
JP7402599B2 (en) * | 2017-11-17 | 2023-12-21 | ポーラ化成工業株式会社 | Water-in-oil emulsion composition |
JP2019089744A (en) * | 2017-11-17 | 2019-06-13 | ポーラ化成工業株式会社 | Emulsion composition |
FR3075054B1 (en) | 2017-12-15 | 2020-12-25 | Lvmh Rech | COSMETIC COMPOSITION INCLUDING A PULLULAN DERIVATIVE |
WO2020075785A1 (en) * | 2018-10-10 | 2020-04-16 | 株式会社 資生堂 | Elasticity-imparting skin preparation for external use |
JP2020105143A (en) * | 2018-12-28 | 2020-07-09 | 花王株式会社 | Oil-in-water emulsion cosmetic |
JP7231213B2 (en) * | 2019-03-28 | 2023-03-01 | 株式会社ダリヤ | Oil-in-water cosmetic composition |
JP7523243B2 (en) | 2020-04-01 | 2024-07-26 | 花王株式会社 | Skin Treatment Method |
JP7173624B2 (en) * | 2021-01-25 | 2022-11-16 | 東洋ビューティ株式会社 | sunscreen cosmetics |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999049834A1 (en) * | 1998-04-01 | 1999-10-07 | Catalysts & Chemicals Industries Co., Ltd. | Inorganic composite powder and cosmetic comprising the same |
JP2000016919A (en) * | 1998-04-30 | 2000-01-18 | Shiseido Co Ltd | Composition for external use |
JP2002017689A (en) * | 2000-07-07 | 2002-01-22 | Naris Cosmetics Co Ltd | Method of measuring and evaluating quality sensation of skin, and use of compound showing effectiveness by this method |
JP2002080747A (en) * | 2000-09-11 | 2002-03-19 | Catalysts & Chem Ind Co Ltd | Colored composite powder and cosmetic formulated with the same |
JP2002285019A (en) * | 2000-12-22 | 2002-10-03 | Shiseido Co Ltd | Gel composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0517329A (en) * | 1991-07-04 | 1993-01-26 | Teika Corp | Scaly pigment composition, its production and cosmetic containing the same scaly pigment composition blended therein |
JP3515874B2 (en) * | 1996-05-16 | 2004-04-05 | 株式会社資生堂 | Lipstick composition |
JP3515872B2 (en) * | 1996-05-16 | 2004-04-05 | 株式会社資生堂 | Cosmetics |
JPH11106310A (en) * | 1997-09-30 | 1999-04-20 | Shiseido Co Ltd | W/o emulsion composition |
-
2004
- 2004-05-17 JP JP2004146642A patent/JP4570905B2/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999049834A1 (en) * | 1998-04-01 | 1999-10-07 | Catalysts & Chemicals Industries Co., Ltd. | Inorganic composite powder and cosmetic comprising the same |
JP2000016919A (en) * | 1998-04-30 | 2000-01-18 | Shiseido Co Ltd | Composition for external use |
JP2002017689A (en) * | 2000-07-07 | 2002-01-22 | Naris Cosmetics Co Ltd | Method of measuring and evaluating quality sensation of skin, and use of compound showing effectiveness by this method |
JP2002080747A (en) * | 2000-09-11 | 2002-03-19 | Catalysts & Chem Ind Co Ltd | Colored composite powder and cosmetic formulated with the same |
JP2002285019A (en) * | 2000-12-22 | 2002-10-03 | Shiseido Co Ltd | Gel composition |
Also Published As
Publication number | Publication date |
---|---|
JP2005325088A (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4570905B2 (en) | Topical skin preparation | |
EP2868701B1 (en) | Aqueous dispersion comprising silicone elastomer particles, a silicone elastomer particle and a cosmetic | |
JP4276169B2 (en) | Oil-in-water emulsified composition containing powder | |
US8901265B2 (en) | Cationic (meth) acrylic silicone-based graft copolymer and cosmetic containing same | |
JP4800115B2 (en) | Anti-shine agent and cosmetics containing the same | |
JP5851724B2 (en) | Oil-in-water makeup cosmetics | |
KR102516515B1 (en) | Gel paste composition and cosmetic using the gel paste composition | |
JP5851726B2 (en) | Oil-in-water emulsified makeup cosmetics | |
JP5273743B2 (en) | Cosmetic composition and cosmetics | |
JP7189202B2 (en) | Phosphorylcholine group- and silicone group-containing copolymer, powder coated with the copolymer, production method thereof, and use of the copolymer and powder in cosmetics | |
EP3292857A1 (en) | Cosmetic composition | |
JP2001278729A (en) | Water-in-oil type emulsion composition | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP2010229094A (en) | External skin care preparation for correcting uneven skin | |
JP2012162700A (en) | Paste composition and cosmetic containing the same | |
JP2017002017A (en) | Emulsified makeup cosmetic | |
JP6286138B2 (en) | Fructooligosaccharide fatty acid ester and cosmetics | |
JP5851722B2 (en) | Makeup cosmetics | |
JP2002003334A (en) | Cosmetic | |
JP4359281B2 (en) | Sunscreen cosmetics | |
JP2005068028A (en) | Skin care preparation for external use | |
JP2006225330A (en) | Skin lotion composition | |
JP3976934B2 (en) | Cosmetics | |
JP2003040756A (en) | Water-slippery cosmetic | |
JP2003267853A (en) | Bleaching cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060911 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080313 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080408 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080609 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090908 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100216 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100803 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100811 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130820 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4570905 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |